syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.079415689999998	100.0
SMITH-MAGENIS SYNDROME; SMS	5.150549014	63.74902853896853
PANDAS	2.7727338100000005	34.31849426229982
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.21471485	27.41181955449059
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	25.01009673881504
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.992287530139453
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930273
NARCOLEPSY 1; NRCLP1	1.8373013	22.740521969602984
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.42459584	17.63241173199247
CRI-DU-CHAT SYNDROME	1.41072984	17.460790410203543
MONOSOMY 22Q13.3	1.389194554	17.194245318005173
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	1.3736082	17.001330946495717
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	1.3736082	17.001330946495717
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	1.3736082	17.001330946495717
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	1.3736082	17.001330946495717
DIGEORGE SYNDROME; DGS	1.300287854	16.093835295656145
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	1.2636986	15.640965244109134
BRAIN-LUNG-THYROID SYNDROME	1.2440830339999998	15.398180781065864
16P12.1P12.3 TRIPLICATION SYNDROME	1.21163592	14.99657854589235
CITRULLINEMIA TYPE II	1.188060604	14.704783731705731
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.1380929599999998	14.086327572037579
TRICHOTHIODYSTROPHY	1.1349858839999998	14.047870880127968
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.11146498	13.756749530484925
SCHIZOPHRENIA	1.0894928	13.484796943279944
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.2022752749339
IMMUNODEFICIENCY 61; IMD61	1.05620014	13.072729273074454
IMMUNODEFICIENCY 13; IMD13	1.03703706	12.835545289290598
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	1.0175439	12.59427586155058
DISTAL 16P11.2 MICRODELETION SYNDROME	1.012721444	12.534587683778408
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	12.524479972635252
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	1.0111107	12.514651291571314
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.00671141	12.460200695528274
PROLIDASE DEFICIENCY	1.00359712	12.421654714983484
CHAR SYNDROME	1.0017908839999998	12.39929869235383
BROWN SYNDROME	1.0	12.377132683465137
TARDIVE DYSKINESIA	1.0	12.377132683465137
STRABISMUS, SUSCEPTIBILITY TO	1.0	12.377132683465137
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	1.0	12.377132683465137
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	1.0	12.377132683465137
SECRETORY COMPONENT DEFICIENCY	1.0	12.377132683465137
KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	1.0	12.377132683465137
LEISHMANIASIS, TEGUMENTARY	1.0	12.377132683465137
CORONAVIRUS 229E SUSCEPTIBILITY	1.0	12.377132683465137
PLUMMER-VINSON SYNDROME	1.0	12.377132683465137
POLYEMBRYOMA	1.0	12.377132683465137
CARTILAGE-HAIR HYPOPLASIA; CHH	1.0	12.377132683465137
AASE-SMITH SYNDROME I	1.0	12.377132683465137
KIFAFA SEIZURE DISORDER	1.0	12.377132683465137
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.980114454	12.131006642139987
DUPLICATION/INVERSION 15Q11	0.9452355800000001	11.699306190792127
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.9085285000000001	11.244977791209557
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.8488347199999999	10.506139955771978
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137847
7Q11.23 MICRODUPLICATION SYNDROME	0.8368654199999999	10.357994341543778
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328386
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	9.433789883386979
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.74627125	9.236698279105383
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.72621612	8.98847327411124
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609605
POSTENCEPHALITIC PARKINSONISM	0.70087304	8.674798610343567
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.7005455540000001	8.670745272669592
ACUTE ADRENAL INSUFFICIENCY	0.666667	8.251425914687653
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505	8.221516573558059
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.186937835352301
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772607
48,XXXY SYNDROME	0.6482769640000001	8.023809999061953
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.6448411	7.981283854451609
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.6317457999999999	7.819201588821828
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.652028113434032
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.5946782340000001	7.3604114061867305
XQ12-Q13.3 DUPLICATION SYNDROME	0.59194947	7.326637132096865
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.58233251	7.2076067421652885
IMMUNODEFICIENCY 21; IMD21	0.5804094	7.183804154530389
MUCOPOLYSACCHARIDOSIS TYPE 2	0.567459044	7.023515880020281
BARE LYMPHOCYTE SYNDROME, TYPE II	0.5671252	7.019383848536702
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.56415163	6.98257957810313
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.916744619189165
MANGANESE POISONING	0.5354894899999999	6.6278244683310765
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.5350125840000001	6.621921739491538
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52677921	6.5200161770609455
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52677921	6.5200161770609455
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52677921	6.5200161770609455
MANNOSE-BINDING LECTIN DEFICIENCY	0.525	6.497994658819197
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.5140845	6.362892067012833
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.513052284	6.3501161926228376
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	6.339506712520694
MOMO SYNDROME	0.5082875800000001	6.2911428190174
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.503557604	6.232599278475795
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.50190476	6.212141808982725
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.500545554	6.195318735976564
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.5	6.188566341732568
SEMANTIC DEMENTIA	0.5	6.188566341732568
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.188566341732568
ZUNICH NEUROECTODERMAL SYNDROME	0.5	6.188566341732568
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.188566341732568
VIRAL HEMORRHAGIC FEVER	0.5	6.188566341732568
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.5	6.188566341732568
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	6.188566341732568
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.188566341732568
BARTH SYNDROME; BTHS	0.5	6.188566341732568
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.0168181543336345
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48350111000000007	5.984357391072673
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.4780297100000001	5.9166371473083625
IDIOPATHIC BRONCHIECTASIS	0.47549050000000004	5.88520900822718
16P13.2 MICRODELETION SYNDROME	0.46182036400000004	5.716011921154167
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.4591872	5.683420900948843
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.458333	5.672848354210626
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.458333	5.672848354210626
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.45177921000000004	5.59173122580106
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.45177921000000004	5.59173122580106
AUTISM	0.45177921000000004	5.59173122580106
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.568155758550903
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.568155758550903
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.568155758550903
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44473696000000007	5.504568363160929
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574127
WILLIAMS SYNDROME	0.42132148	5.214751860353903
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.064797451955342
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.009788028371642
CHILDHOOD DISINTEGRATIVE DISORDER	0.40057911	4.958020794694376
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.4	4.950853073386055
PALLISTER-HALL SYNDROME	0.39641460399999995	4.906476151371289
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338743
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.39560000999999995	4.896393813350134
11Q22.2Q22.3 MICRODELETION SYNDROME	0.395377834	4.893643911519053
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.392857	4.862443214628064
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.39047610000000005	4.832974499422002
LEUKOCYTE ADHESION DEFICIENCY	0.38353785	4.747098858580949
CHROMOSOME 17Q12 DELETION SYNDROME	0.38266461	4.73629065123644
CHILDHOOD APRAXIA OF SPEECH	0.37655271	4.66064285398837
IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACEGLYCOPROTEIN	0.3748094	4.639065674809958
49,XXXXY SYNDROME	0.371010144	4.592041779199507
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.3702381	4.582486088174034
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.366616654	4.537662970526029
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.363765514	4.5023740324468955
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36324359000000006	4.4959141098482105
ATYPICAL TERATOID RHABDOID TUMOR	0.36277170999999997	4.490073588477536
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.438032572625312
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.358103654	4.43229643999169
ESOPHAGEAL ATRESIA	0.35359712	4.376518470731144
ANGELMAN SYNDROME	0.353196784	4.371563458941176
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852048
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829093
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.34940190000000004	4.324593676154818
ADNP SYNDROME	0.34824543	4.31027989352037
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.34554629	4.2768722796091225
NON-DISTAL MONOSOMY 20Q	0.34535919	4.274556518084046
PAPILLON-LEFÈVRE SYNDROME	0.34450622000000003	4.263999195219031
POSTERIOR CORTICAL ATROPHY	0.34280516000000005	4.242944949896496
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.342057784	4.233694577980058
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.3409091	4.2194771637006845
ACNE INVERSA, FAMILIAL, 3; ACNINV3	0.3409091	4.2194771637006845
PLACENTAL INSUFFICIENCY	0.34037525	4.212869631417617
SPINOCEREBELLAR ATAXIA TYPE 42	0.33902277	4.1961298070058834
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361184
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361184
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361184
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.3368295	4.16898341320522
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.335783314	4.156034630271637
PRADER-WILLI SYNDROME	0.3357178	4.155223754801012
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.33553349	4.1529425254761225
POTOCKI-LUPSKI SYNDROME	0.33485390400000004	4.144531199384298
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.333878554	4.13245916302148
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	4.13245916302148
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.333878554	4.13245916302148
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.3337032	4.130288783296903
MAST SYNDROME	0.333333	4.125706768777484
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	4.125706768777484
PITUITARY CARCINOMA	0.333333	4.125706768777484
ANAPLASTIC THYROID CARCINOMA	0.333333	4.125706768777484
VARICELLA, SEVERE RECURRENT	0.333333	4.125706768777484
ISOLATED CLEFT LIP	0.333333	4.125706768777484
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.069538102946652
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.3196921	3.9568715395556042
ADULT IDIOPATHIC NEUTROPENIA	0.3163302	3.915260857187063
CHROMOSOME 1P36 DELETION SYNDROME	0.31426708400000003	3.8897253967136844
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.8560376387812783
GITELMAN SYNDROME	0.31040850000000003	3.8419671905753883
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.303526904	3.756792763809385
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.297372674	3.6806210425348236
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.29428116400000004	3.642357013072565
LEPTIN DEFICIENCY OR DYSFUNCTION	0.2940294	3.6392408966396443
MYOCLONUS-DYSTONIA SYNDROME	0.29335655	3.6309129429135742
2Q23.1 MICRODELETION SYNDROME	0.29246644	3.619895933340695
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882265
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882265
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.28951177399999994	3.583325640223371
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28927411000000003	3.58038404136129
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2878137	3.5623083530190303
CHRISTIANSON SYNDROME	0.28332508999999995	3.506752231484701
HYPERTRYPTOPHANEMIA; HYPTRP	0.27851856399999997	3.4472612214361757
ALLAN-HERNDON-DUDLEY SYNDROME	0.27840452	3.445849683716423
21Q22.11Q22.12 MICRODELETION SYNDROME	0.2777728	3.4380308014576246
WILLIAMS-BEUREN SYNDROME; WBS	0.27687041	3.4268618006953933
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.27648079999999997	3.4220395460305877
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.2758749	3.414540241337676
1P21.3 MICRODELETION SYNDROME	0.275444964	3.409218866420278
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.275405	3.408724226689716
SYDENHAM CHOREA	0.27415041	3.3931959997963674
MARFAN SYNDROME; MFS	0.27066968	3.3501145427510504
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	3.3501145427510504
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.26805249999999997	3.3177213586345378
PRADER-WILLI-LIKE SYNDROME	0.267990744	3.316956996428538
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.26731352999999997	3.308575028895438
LYSINURIC PROTEIN INTOLERANCE	0.2636986	3.263832560644
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.263143404	3.256960826086671
WILSON DISEASE	0.25918378	3.2079520344620374
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	3.199174171962924
CHOANAL ATRESIA	0.25756512	3.18791766487262
PREECLAMPSIA	0.25724638	3.183972577601092
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.1010355651102794
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25	3.094283170866284
GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS	0.25	3.094283170866284
HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	0.25	3.094283170866284
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	3.094283170866284
MÉNÉTRIER DISEASE	0.25	3.094283170866284
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	3.094283170866284
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.24995319000000002	3.0937037972853716
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.2460001	3.0447758778456917
CONGENITAL MYASTHENIC SYNDROME	0.2460001	3.0447758778456917
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.243046384	3.008217343004418
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.003718948393409
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.239857604	2.968749389846038
ADENYLOSUCCINASE DEFICIENCY	0.23963494400000002	2.965993497482738
SPASTIC PARAPLEGIA 16, X-LINKED	0.23927943000000002	2.9615932535339087
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.9511245509389066
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.23790247400000003	2.9445504864226155
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.8746893205095145
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.2294584	2.840037062135617
PHELAN-MCDERMID SYNDROME	0.228044044	2.8225313902619615
PITT-HOPKINS-LIKE SYNDROME	0.22800763000000002	2.8220806893524264
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.22798128399999998	2.821754601414747
NARCOLEPSY 7; NRCLP7	0.2261903	2.7995873548127848
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.791037850411681
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.22545869400000002	2.7905321702787655
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.778926207224276
POPOV-CHANG SYNDROME; POPCHAS	0.223889314	2.771107745787989
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.753540831861816
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.22222199999999998	2.750471179184989
POLYARTERITIS NODOSA	0.2208333	2.733283055027462
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.22048752400000002	2.7290033395967037
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417234
PARAGANGLIOMAS 4	0.216667	2.681716207128341
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.216667	2.681716207128341
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004000000003	2.657618424878942
SCHIZOPHRENIA 10	0.2144928	2.6548058452479513
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.21211576400000004	2.625384955282578
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21037934000000003	2.603893005039825
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344067
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.591407077360072
CLEFT VELUM	0.20925926	2.590029626263729
NARCOLEPSY TYPE 1	0.20893710000000001	2.586042209198424
VELOCARDIOFACIAL SYNDROME	0.2089071	2.5856708952179197
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.583997878193096
RHABDOID TUMOR	0.20671141	2.5584945487561623
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.5556531304060193
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.5460857306130276
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.5460857306130276
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.20470840400000004	2.533703077728386
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767272
APNEA, OBSTRUCTIVE SLEEP	0.2036865	2.5210548363306216
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.20339339000000003	2.5174269749697715
MUCOLIPIDOSIS TYPE II	0.20148103000000003	2.49375744151122
TRANSALDOLASE DEFICIENCY	0.20054555400000001	2.482178930937023
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	2.4754265366930275
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.2	2.4754265366930275
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.2	2.4754265366930275
BENIGN SCHWANNOMA	0.2	2.4754265366930275
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	2.4754265366930275
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	2.4754265366930275
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	2.4754265366930275
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.4754265366930275
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	2.4754265366930275
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	2.4754265366930275
EPISODIC ATAXIA, TYPE 4	0.2	2.4754265366930275
MALARIA	0.2	2.4754265366930275
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	2.4754265366930275
RADIATION PROCTITIS	0.2	2.4754265366930275
PULMONARY ARTERIOVENOUS MALFORMATION	0.2	2.4754265366930275
FAMILIAL ADENOMATOUS POLYPOSIS	0.2	2.4754265366930275
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2	2.4754265366930275
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.4754265366930275
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	2.4754265366930275
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.4754265366930275
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.199729394	2.4720772103260855
8Q24.3 MICRODELETION SYNDROME	0.19910860400000002	2.4643936101275172
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.198029534	2.4510378175627707
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781045
PROGRESSIVE NON-FLUENT APHASIA	0.19787205000000002	2.449088617199248
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.19763953999999997	2.446210810079015
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.1970761	2.4392370384398436
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.433809170672837
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.19449443000000002	2.4072833663049225
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.3784708866737376
MONOSOMY X	0.19200631999999998	2.3764876987038654
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19200631999999998	2.3764876987038654
MOSAIC MONOSOMY X	0.19200631999999998	2.3764876987038654
TURNER SYNDROME	0.19200631999999998	2.3764876987038654
DRACUNCULIASIS	0.1909091	2.362907261180914
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.189646084	2.3472747445675743
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.189525514	2.3457824336799296
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.189306384	2.3430702325950015
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.18826225400000002	2.3301468970462156
TRIGEMINAL NEURALGIA	0.18777814	2.324154953834292
GITELMAN SYNDROME	0.1870752	2.315454572185777
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.311359102752146
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18629060000000003	2.305743473882331
DDOST-CDG	0.18539768	2.2946916845666108
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.1852756	2.2931806842086138
CUSHING DISEASE	0.18523062999999998	2.2926240845518375
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263578
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263578
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.275064275099826
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18370770400000003	2.2737746273827395
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.18333370000000002	2.2691455302505927
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18292109999999998	2.264038725305394
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.2632453511003843
SOTOS SYNDROME	0.18199121399999998	2.2525294029028977
WITTEVEEN-KOLK SYNDROME	0.18076855399999997	2.237396377856132
XIA-GIBBS SYNDROME	0.180448534	2.2334354478547698
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.17894343000000001	2.214806575944356
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17838315	2.207871916044464
PITT-HOPKINS SYNDROME	0.17769443400000004	2.199347586731239
BARDET-BIEDL SYNDROME 16; BBS16	0.176471814	2.1842150567697804
PLAGUE	0.17603755000000001	2.1788401136221283
2Q32Q33 MICRODELETION SYNDROME	0.175971204	2.178018940377111
INSULINOMA	0.17526791	2.169314177223626
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.17479859999999997	2.163505465083949
KOOLEN-DE VRIES SYNDROME; KDVS	0.17420605399999997	2.156171444620892
IMMUNODEFICIENCY 46; IMD46	0.173611	2.1488063823090657
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090657
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286090999999998	2.139522418854525
CHROMOSOME 16P13.2 DELETION SYNDROME	0.17205199400000004	2.129510358192748
AURICULOCONDYLAR SYNDROME	0.17197395399999998	2.12854444675813
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.128271407211133
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.170542214	2.1108236108099057
TRISOMY 8P	0.16983503	2.102070700610282
KOOLEN-DE VRIES SYNDROME	0.168457884	2.085025581843779
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.168457884	2.085025581843779
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.16836796399999998	2.083912630072881
MCLEOD SYNDROME; MCLDS	0.16835655	2.0837713574804324
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.0775883608484076
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.167212554	2.069611967199079
CEREBROOCULONASAL SYNDROME	0.166667	2.062859572955084
ONDINE SYNDROME	0.166667	2.062859572955084
MELIOIDOSIS	0.166667	2.062859572955084
PARAGANGLIOMAS 3	0.166667	2.062859572955084
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.062859572955084
DERMATOLEUKODYSTROPHY	0.166667	2.062859572955084
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.166667	2.062859572955084
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.062859572955084
PARAGANGLIOMAS 1	0.166667	2.062859572955084
AL AMYLOIDOSIS	0.166667	2.062859572955084
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.062859572955084
ADDISON DISEASE	0.166667	2.062859572955084
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.062859572955084
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.062859572955084
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.166667	2.062859572955084
MICROSPORIDIOSIS	0.166667	2.062859572955084
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.16621242000000003	2.057233175979835
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.16620086	2.0570900963260135
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.165421544	2.0474443987916664
PERRY SYNDROME	0.16532722	2.0462769381284307
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515104
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.1641336	2.0315033450147935
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.1637426	2.0266638861355584
PGM3-CDG	0.161764	2.002174491408054
MELAS	0.16137008	1.9972988913013838
49,XYYYY SYNDROME	0.16107896000000002	1.9936956604345735
MYOTONIC DYSTROPHY 1	0.16025640000000002	1.9835147261744628
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.9815591392104746
SPINOCEREBELLAR ATAXIA TYPE 7	0.15999620399999998	1.9802942457587551
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.159638054	1.9758613756881724
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.15963097399999998	1.9757737455887732
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.1589598	1.9674665359370815
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.9449760481379568
VICI SYNDROME; VICIS	0.156178974	1.9330478835654519
CHRONIC HICCUP	0.15454781999999997	1.9128588740802865
LENNOX-GASTAUT SYNDROME	0.15430775	1.9098874958369674
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.1536037	1.901173375571174
DRAVET SYNDROME	0.15188942000000002	1.8799555045545635
L-2-HYDROXYGLUTARIC ACIDURIA	0.15162893	1.8767313852618472
DIENCEPHALIC SYNDROME	0.15162893	1.8767313852618472
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.15094827400000002	1.868306815638051
BECKWITH-WIEDEMANN SYNDROME	0.15076845	1.8660811101303791
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.14925531	1.8473527755817207
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454784
COFFIN-SIRIS SYNDROME 1; CSS1	0.147090804	1.8205623976255643
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1468253	1.8172762193895735
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14645412	1.812682075280125
17Q24.2 MICRODELETION SYNDROME	0.14643327	1.812424012063675
3Q27.3 MICRODELETION SYNDROME	0.14511246	1.7960761714440272
49,XXXYY SYNDROME	0.14506307	1.7954648648607907
EMANUEL SYNDROME	0.144564074	1.7892887251602725
NIJMEGEN BREAKAGE SYNDROME	0.144376	1.7869609083079627
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001193
8Q22.1 MICRODELETION SYNDROME	0.143402554	1.774912438005774
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.774912438005774
PRIMARY BILIARY CHOLANGITIS	0.14336909999999997	1.7744983734089812
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617788
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617788
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.14285699999999998	1.7681600437617788
INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	0.14285699999999998	1.7681600437617788
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.14285699999999998	1.7681600437617788
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617788
LI-FRAUMENI SYNDROME	0.14285699999999998	1.7681600437617788
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617788
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617788
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617788
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.14285699999999998	1.7681600437617788
NEUROBLASTOMA	0.14285699999999998	1.7681600437617788
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.14285699999999998	1.7681600437617788
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617788
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617788
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617788
PERINEURAL CYST	0.14285699999999998	1.7681600437617788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.140651204	1.7408586139971225
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971432
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.140179534	1.7350206918243123
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.13968239999999998	1.7288675983448503
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525000000003	1.7194962523335653
IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTSAND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES	0.1386986	1.7166909752108577
LUSCAN-LUMISH SYNDROME; LLS	0.13822633400000003	1.7108456762669686
CYSTIC FIBROSIS	0.13710029999999998	1.6969086040428751
ADRENOCORTICAL CARCINOMA	0.13663752	1.6911807145796214
48,XYYY SYNDROME	0.13660195400000003	1.6907405094786017
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13483588000000002	1.6688815772517833
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13402696	1.6588694670814745
GRAFT VERSUS HOST DISEASE	0.13171141	1.630209597496277
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.6232720908558678
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.13053441	1.6156417123278384
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.1302778	1.6124656163099345
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.6081127025164867
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668085
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12915187	1.5985298313076404
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.12859712	1.5916636169514882
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.12856165	1.5912246000552057
17P11.2 MICRODUPLICATION SYNDROME	0.12770059400000003	1.5805671956953125
TETRASOMY 9P	0.12765052400000002	1.579947472661851
USHER SYNDROME	0.12682065	1.569676012053293
HSD10 DISEASE	0.12668632400000002	1.568013441328454
LISSENCEPHALY, X-LINKED, 2	0.12645501000000003	1.5651504372589113
SMITH-MAGENIS SYNDROME	0.12632621400000002	1.5635563120778115
TONNE-KALSCHEUER SYNDROME; TOKAS	0.125881294	1.558049478204284
BRUNNER SYNDROME; BRNRS	0.12551649	1.5535342506928251
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.1251955	1.5495613148727594
KAPOSI SARCOMA	0.125	1.547141585433142
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.547141585433142
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.547141585433142
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.547141585433142
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.547141585433142
IMMUNODEFICIENCY 25	0.125	1.547141585433142
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.547141585433142
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.12496516000000002	1.5467103661304504
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.5217845537045271
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.5217845537045271
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.12237621	1.5146665884695931
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12167381399999999	1.5059729399812578
X-LINKED AGAMMAGLOBULINEMIA	0.1216603	1.5058056754101736
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.12149258000000002	1.503729782716503
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.12125159999999999	1.5007471412824411
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511919
MOHR-TRANEBJAERG SYNDROME	0.11965903	1.4810356910847353
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.119613294	1.4804696105443242
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.11952466400000002	1.4793726252745891
FG SYNDROME TYPE 1	0.119509974	1.4791908051954687
MYCETOMA	0.1192983	1.476570888011829
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11906773999999999	1.4737172163003291
COG8-CDG	0.11851840999999999	1.466918086003321
TRISOMY XQ28	0.11851840999999999	1.466918086003321
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.117888004	1.4591154672968687
RABIES	0.11694683	1.4474664318206412
INTESTINAL LYMPHANGIECTASIA	0.11666670000000001	1.4439992256420222
ROLANDIC EPILEPSY	0.11662072999999998	1.443430248852563
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11515305399999999	1.4252646282642258
LIGNEOUS CONJUNCTIVITIS	0.11498661400000001	1.42320457830039
WIEDEMANN-STEINER SYNDROME	0.11480910999999999	1.421007587740544
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000001	1.4189032771502323
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153128
HENNEKAM-BEEMER SYNDROME	0.11411882000000001	1.412463776820475
HADDAD SYNDROME	0.11374533	1.4078410415345277
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.11369860000000001	1.4072626581242293
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.113502844	1.4048397601386449
STEINERT MYOTONIC DYSTROPHY	0.11235632999999999	1.3906492042371943
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.3902967034983695
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999999	1.3849386427596972
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999999	1.3849386427596972
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.11165655399999999	1.38198798383649
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.11165655399999999	1.38198798383649
W SYNDROME	0.11165655399999999	1.38198798383649
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.11126539399999999	1.3771465446160256
BEHÇET DISEASE	0.11125686000000001	1.377040918165705
TRACHEOBRONCHOMEGALY	0.11111099999999999	1.3752355895924946
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.11111099999999999	1.3752355895924946
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.11111099999999999	1.3752355895924946
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	1.3752355895924946
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11111099999999999	1.3752355895924946
MOUNIER-KÜHN SYNDROME	0.11111099999999999	1.3752355895924946
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	1.3752355895924946
MUCKLE-WELLS SYNDROME	0.11111099999999999	1.3752355895924946
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.11111099999999999	1.3752355895924946
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.11111099999999999	1.3752355895924946
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11111099999999999	1.3752355895924946
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	1.3752355895924946
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	1.3752355895924946
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.11111099999999999	1.3752355895924946
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11111099999999999	1.3752355895924946
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924946
ULNAR-MAMMARY SYNDROME	0.11111099999999999	1.3752355895924946
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1104094	1.3665517933017757
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.110274644	1.3648839004098827
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.110026724	1.361815361674998
22Q11.2 DELETION SYNDROME	0.10903951399999999	1.3495965325185542
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10868672	1.3452299543706239
MOWAT-WILSON SYNDROME; MOWS	0.10818997000000001	1.3390816137101127
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.107255364	1.3275138712413501
HURLER SYNDROME	0.107154724	1.3262682366080862
DISTAL MONOSOMY 12Q	0.10715121400000002	1.3262247928723674
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.10698568400000001	1.3241760060992733
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.10646665399999998	1.317751902922574
HUNTINGTON DISEASE-LIKE 1	0.1063492	1.3162981591803706
TRICHOHEPATOENTERIC SYNDROME 1	0.10633490000000001	1.3161211661829972
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.10601279999999999	1.3121344917456528
YOUNG SYNDROME	0.1059783	1.3117074806680733
YOUNG SYNDROME	0.1059783	1.3117074806680733
DEMENTIA, LEWY BODY; DLB	0.1055556	1.3064756666827726
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10550188	1.305810767115017
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10487747400000001	1.2980824112046654
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.2947706123040197
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179651
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.10393371	1.2864013189547874
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.103693394	1.2834268959368278
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106447
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.2810685570753204
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.10349451400000001	1.2809653317887404
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.2785833030952767
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.1029843	1.2746503454137788
MYASTHENIA GRAVIS	0.1029573	1.274316162831325
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.2694660596179825
SPINOCEREBELLAR ATAXIA TYPE 29	0.10245031400000001	1.2680411298406662
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.10218380400000002	1.2647425002091957
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10179088400000001	1.2598792772352085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.10179088400000001	1.2598792772352085
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.10173595400000002	1.2591994013369059
ACROMEGALY	0.10163245	1.2579183185956364
SOMATOMAMMOTROPINOMA	0.10163245	1.2579183185956364
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.10138595400000001	1.254867404897693
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.101292234	1.2537074200225986
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.10101929	1.250329155919443
9P13 MICRODELETION SYNDROME	0.10091091999999999	1.2489878460505355
47,XYY SYNDROME	0.10082484	1.2479224224691432
NORRIE DISEASE	0.10058753	1.2449852051120298
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.10054555400000001	1.244465662590509
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.10010446	1.2390061836266284
RING CHROMOSOME 22 SYNDROME	0.10007082400000002	1.2385898663916877
COG4-CDG	0.10003916400000001	1.238198006370929
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	1.2377132683465137
ACQUIRED ICHTHYOSIS	0.1	1.2377132683465137
IMMUNODEFICIENCY 28; IMD28	0.1	1.2377132683465137
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	1.2377132683465137
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	1.2377132683465137
IMMUNODEFICIENCY 30; IMD30	0.1	1.2377132683465137
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.1	1.2377132683465137
CHÉDIAK-HIGASHI SYNDROME	0.09959722400000001	1.2327280563527985
RAMOS-ARROYO SYNDROME	0.09920640000000001	1.227890775848916
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.09837165400000002	1.2175590138499242
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059288
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09646411399999999	1.1939491381709066
1P36 DELETION SYNDROME	0.095644934	1.1838100386192658
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.1814536305904573
ISOLATED AGAMMAGLOBULINEMIA	0.09450622	1.1697160243527465
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09425988400000002	1.1666670909960326
IMMUNODEFICIENCY 36; IMD36	0.09421882000000001	1.1661588364195188
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302327
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.09361615400000002	1.1586995593737057
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09231673	1.1426164161136265
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.092069494	1.1395563433374973
DUANE RETRACTION SYNDROME 1	0.09180788000000001	1.1363183121476452
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166453999999999	1.1345441739487971
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.131914775881522
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.09136941399999998	1.130891360288457
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0910973	1.1275233692054287
CONGENITAL ANALBUMINEMIA	0.0910816	1.1273290482222982
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.09097247400000001	1.1259783812410824
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344006
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344006
PYOMYOSITIS	0.0909091	1.1251939928344006
PEMPHIGUS VULGARIS	0.0909091	1.1251939928344006
KERION CELSI	0.0909091	1.1251939928344006
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09074071000000002	1.123109807461832
PSEUDOMYXOMA PERITONEI	0.09047619999999999	1.1198359320957283
RHEUMATOID ARTHRITIS	0.0901315	1.115569534459738
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.08982525000000001	1.1117790375754268
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.107664259814809
8Q12 MICRODUPLICATION SYNDROME	0.08934333400000001	1.1058142993011422
DUBOWITZ SYNDROME	0.08918935	1.1039084189020114
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.0961265442699364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.090086751063059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.0874455204569382
RIDDLE SYNDROME	0.087729554	1.0858403301192197
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100156
3Q29 MICRODELETION SYNDROME	0.08656963399999998	1.0714838463770144
GABRIELE-DE VRIES SYNDROME	0.08629349	1.068065975449272
FAMILIAL COLORECTAL CANCER TYPE X	0.08603923999999999	1.0649190894645009
LYNCH SYNDROME	0.08603923999999999	1.0649190894645009
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.08597524400000002	1.06412700248129
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08584681999999999	1.0625374815935484
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	1.0606587566235255
NASU-HAKOLA DISEASE	0.08565881	1.0602104568777302
SLC35A2-CDG	0.085630754	1.059863204043163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.08523363	1.0549479476033745
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08496466	1.051618870225503
LAFORA DISEASE	0.08479032	1.0494610409134677
15Q13.3 MICRODELETION SYNDROME	0.084752114	1.0489881601821631
DUANE-RADIAL RAY SYNDROME; DRRS	0.08457863000000002	1.046840925695705
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534558
JACOBSEN SYNDROME	0.084319034	1.0436278715596081
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853624
RETT SYNDROME, CONGENITAL VARIANT	0.08399551	1.0396235720853226
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.08394523400000001	1.0390012993625288
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950008
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	1.0381797052950008
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.08367273399999998	1.0356285307062845
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.035155427186592
HEPATOCELLULAR CARCINOMA	0.0833334	1.0314285487642736
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08333330000000001	1.0314273110510055
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08333330000000001	1.0314273110510055
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.0314273110510055
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08323697	1.030235021859607
SIALURIA	0.08239893400000001	1.0198625390940868
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507969
SUSAC SYNDROME	0.0823679	1.0194784271583879
PHENYLKETONURIA	0.08224078	1.0179050460516659
MEND SYNDROME	0.082207994	1.0174992493795059
NIJMEGEN BREAKAGE SYNDROME	0.08204898	1.0155311120029773
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.0153791208136245
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.081913094	1.0138492329511521
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.08173713	1.0116713031756388
GLASS SYNDROME	0.081630304	1.0103491035995948
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.080999154	1.002537276306426
SPINOCEREBELLAR ATAXIA 12	0.08064715	0.9981804760933154
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.080202354	0.992675176984241
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.08011995	0.9916552517425925
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.08006720399999999	0.9910024075020705
CRANIOPHARYNGIOMA	0.079579164	0.9849618716672321
PRADER-WILLI SYNDROME; PWS	0.079141044	0.9795392022959524
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.078964954	0.9773597130017211
KID SYNDROME	0.07861956	0.9730847256356484
NEUTROPHIL CHEMOTACTIC RESPONSE	0.078235	0.9683249754908949
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07816843000000001	0.9675010297681568
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.07815333	0.9673141350646363
FELTY SYNDROME	0.0770881	0.9541296420162289
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	0.9520874151234572
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234572
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234572
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0766806	0.9490859604477166
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07667009	0.9489558767832135
KLEEFSTRA SYNDROME	0.076331864	0.9447696087042159
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.07603724999999999	0.9411231321358093
FRAXE INTELLECTUAL DISABILITY	0.07602131	0.940925840640835
PRIMROSE SYNDROME; PRIMS	0.07586609	0.9390046621057074
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0753968	0.9331961975086842
SCHAAF-YANG SYNDROME; SHFYNG	0.075308034	0.9320975289489037
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.07502572	0.928603291112504
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07495905	0.9277781076764974
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.07472353	0.9248630453868876
SMITH-FINEMAN-MYERS SYNDROME	0.07451932	0.9223355111215973
CASPASE 8 DEFICIENCY	0.0744048	0.9209180818866868
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.07423871400000001	0.9188624134278209
NIPAH VIRUS DISEASE	0.0739348	0.9151008295254581
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.9149629977758952
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.07330605400000001	0.9073187568592603
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07197415400000001	0.8908336538381532
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.07197415400000001	0.8908336538381532
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07197415400000001	0.8908336538381532
FAMILIAL THYROID DYSHORMONOGENESIS	0.07197415400000001	0.8908336538381532
ATHYREOSIS	0.07197415400000001	0.8908336538381532
THYROID ECTOPIA	0.07197415400000001	0.8908336538381532
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.07197415400000001	0.8908336538381532
THYROID HEMIAGENESIS	0.07197415400000001	0.8908336538381532
IMMUNODEFICIENCY 60; IMD60	0.07175926	0.8881738822872725
ALZHEIMER DISEASE 4	0.07142860000000001	0.884081259594158
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.884081259594158
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.884081259594158
H SYNDROME	0.0714285	0.8840800218808895
XP22.13P22.2 DUPLICATION SYNDROME	0.07115971999999998	0.8807532961582275
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524649
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.875005529019884
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471946
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.069895644	0.865107659784244
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875294
FLOATING-HARBOR SYNDROME	0.06907224000000001	0.854916279224148
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06849176	0.84773160124405
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.068316064	0.8455569885400961
WRINKLY SKIN SYNDROME	0.067962364	0.8411791967099544
DE BARSY SYNDROME	0.067962364	0.8411791967099544
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.8410731989456534
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06791203	0.8405562061134648
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0677778	0.8388948235933634
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067604894	0.8367547430895961
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064405
SMITH-LEMLI-OPITZ SYNDROME	0.067351624	0.8336199866948548
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.067075814	0.8302062497294282
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726276
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726276
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726276
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726276
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726276
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726276
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002707
CILIARY DYSKINESIA, PRIMARY, 33	0.06682206	0.8270655028024684
MEIGE DISEASE	0.0666667	0.8251425914687651
BULLOUS IMPETIGO	0.0666667	0.8251425914687651
GLIOBLASTOMA	0.0666667	0.8251425914687651
CRANIOECTODERMAL DYSPLASIA 1	0.0666667	0.8251425914687651
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	0.8251425914687651
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.0666667	0.8251425914687651
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0666667	0.8251425914687651
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	0.8251425914687651
HAIM-MUNK SYNDROME	0.0666667	0.8251425914687651
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	0.8251425914687651
DESMOID TUMOR	0.0666667	0.8251425914687651
FLOATING-HARBOR SYNDROME	0.06660574400000001	0.824388130968912
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0665147	0.8232612673008785
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.06584025399999999	0.8149135596710461
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.06524394399999998	0.8075329516805689
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06522877	0.8073451410692302
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765601
22Q11.2 MICRODUPLICATION SYNDROME	0.064583554	0.7993592170277355
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.7982359427281803
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	0.7959932062859365
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394998
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.795700858411953
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.7904451565605732
AUTOIMMUNE HYPOPARATHYROIDISM	0.06370096	0.7884352339841053
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518369
AMISH INFANTILE EPILEPSY SYNDROME	0.06346611	0.7855284643733936
KLEEFSTRA SYNDROME	0.06338615	0.7845387888440237
IMMUNODEFICIENCY 58; IMD58	0.06312092	0.7812560019423882
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605662
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.777308439244324
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057	0.7760532742188936
CILIARY DYSKINESIA DUE TO TRANSPOSITION OF CILIARY MICROTUBULES	0.0625	0.773570792716571
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0625	0.773570792716571
CILIARY DYSKINESIA, PRIMARY, 34; CILD34	0.0625	0.773570792716571
DYSTONIA 12; DYT12	0.06247675	0.7732830243816805
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816805
LEGIONELLOSIS	0.0621118	0.7687659898088499
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701816
CENTRAL DIABETES INSIPIDUS	0.06203684999999999	0.767838323714224
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411906
13Q12.3 MICRODELETION SYNDROME	0.06185108	0.7655390237756169
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.7655281318988554
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.06134204	0.7592385681544258
PERRY SYNDROME	0.060733920000000004	0.751711786226957
ALG11-CDG	0.060614384	0.7502322732945063
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.060523259999999995	0.7491044194558582
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.06047538	0.7485118023429739
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.060378009999999996	0.7473066409335848
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215695
TURNPENNY-FRY SYNDROME; TPFS	0.059175664	0.7324250449601513
CHARGE SYNDROME	0.058998013999999994	0.7302262473389337
1Q21.1 MICRODELETION SYNDROME	0.058926594	0.7293422725226807
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0588235	0.7280662644058116
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0588235	0.7280662644058116
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0588235	0.7280662644058116
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0588235	0.7280662644058116
FANCONI-LIKE SYNDROME	0.0588235	0.7280662644058116
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.05881001	0.7278992968859116
16P13.11 MICRODELETION SYNDROME	0.057663813999999994	0.7137126769126544
N-ACETYLASPARTATE DEFICIENCY; NACED	0.057651204	0.713556601269516
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.057621950000000005	0.713194520629994
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.057621950000000005	0.713194520629994
WOLFRAM SYNDROME	0.057531979999999996	0.7120809500024625
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.057407410000000006	0.7105391305840835
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.057346484	0.7097850413982105
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325444	0.7095246265265505
MEDULLOBLASTOMA	0.057256964	0.7086770404803867
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267634
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.057005480000000004	0.7055643896446182
ALEXANDER DISEASE	0.05690614	0.7043348452838428
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363916
BABESIOSIS	0.05660889	0.7006557425936828
MIETENS SYNDROME	0.056400784	0.6980799870194575
PFAPA SYNDROME	0.056390930000000006	0.6979580227539948
RHEUMATIC FEVER	0.056390930000000006	0.6979580227539948
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.056390930000000006	0.6979580227539948
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05607038	0.6939905328723099
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539005
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	0.6876190325095158
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095158
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	0.6876190325095158
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	0.6876190325095158
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504075
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091229
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.05515545400000001	0.682666372374758
FILIPPI SYNDROME	0.05515545400000001	0.682666372374758
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.05515545400000001	0.682666372374758
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.05515545400000001	0.682666372374758
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.05515545400000001	0.682666372374758
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.05515545400000001	0.682666372374758
HYPERTRICHOSIS CUBITI	0.05515545400000001	0.682666372374758
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05509279	0.6818907717322813
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.6785769182276102
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0546318	0.6761850373365307
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.054620810000000006	0.6760490126483394
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307628
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307628
HYDROXYKYNURENINURIA	0.054333154	0.6724886561691445
KAWASAKI DISEASE	0.05433041	0.6724546933170612
48,XXYY SYNDROME	0.054230334	0.6712160393866305
1Q21.1 MICRODUPLICATION SYNDROME	0.053790414	0.6657710911765207
LICHTENSTEIN SYNDROME	0.05378683000000001	0.6657267315329832
DISTAL MONOSOMY 7Q36	0.05362623	0.6637389640240186
SIMPSON-GOLABI-BEHMEL SYNDROME	0.053557604	0.6628895709164832
BIOTINIDASE DEFICIENCY	0.053177154	0.6581806907870588
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.053016624	0.6561937896773822
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.053012050000000005	0.656137176672488
OCULOCEREBRORENAL SYNDROME OF LOWE	0.052903030000000004	0.6547878216673366
SCHINZEL-GIEDION SYNDROME	0.052810850000000006	0.6536468975765749
MUCOPOLYSACCHARIDOSIS, TYPE II	0.05274751	0.652862929992404
KEUTEL SYNDROME; KTLS	0.05273756	0.6527397775222037
IMMUNODEFICIENCY 15A; IMD15A	0.0526316	0.6514282965430637
PARKINSON DISEASE, LATE-ONSET; PD	0.05249942	0.6497922871449633
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.052450314	0.649184495667409
RETT SYNDROME; RTT	0.05216591	0.6456643896237009
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.05216445	0.645646319009983
ECTODERMAL DYSPLASIA SYNDROME	0.05216445	0.645646319009983
GIANT CELL ARTERITIS	0.05206344	0.6443961048376262
HUNTINGTON DISEASE; HD	0.05203684	0.644066873108246
ENCEPHALITIS LETHARGICA	0.051617829999999996	0.6388807307425473
GANGLIOCYTOMA	0.0514889	0.6372849470256681
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.05112156	0.6327383311057241
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05092595999999999	0.6303173639528381
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.050741884	0.6280390308769968
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.050741884	0.6280390308769968
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794515
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.050545554	0.625609028417252
DEXTROCARDIA	0.050545554	0.625609028417252
HISTIDINEMIA	0.05043863	0.6242856158822052
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.050368090000000004	0.6234125329427136
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05028286999999999	0.6223577536954286
15Q24 MICRODELETION SYNDROME	0.050267414	0.622166452732673
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726197
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.050100484	0.6201003379738221
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.05	0.6188566341732569
NUT MIDLINE CARCINOMA	0.05	0.6188566341732569
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.05	0.6188566341732569
PLATELET DISORDER, UNDEFINED	0.05	0.6188566341732569
SCHWARTZ-JAMPEL SYNDROME	0.04993078	0.6179998890489073
OROMANDIBULAR DYSTONIA	0.04989894	0.6176058011442659
DESANTO-SHINAWI SYNDROME	0.049881454	0.6173893746021628
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.049824363999999996	0.6166827640972636
MENINGIOMA	0.049802	0.6164059619019308
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04952376	0.6129621485040834
USHER SYNDROME TYPE 1	0.049408904	0.6115405605525913
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.049288894	0.6100551808592486
AICARDI SYNDROME	0.04907410999999999	0.6073967707929632
NEUROFIBROMATOSIS TYPE 1	0.048942780000000005	0.6057712819576438
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085962
USHER SYNDROME TYPE 3	0.04886335	0.6047881663085962
MICROPHTHALMIA, SYNDROMIC 1	0.048487810000000006	0.6001400579006477
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.048405674	0.5991234497305586
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452715
ALSTRÖM SYNDROME	0.04820861399999999	0.5966844119639548
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04773568000000001	0.5908308450954333
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.047658453999999996	0.5898750086468197
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.047619	0.5893866812539263
LUJO HEMORRHAGIC FEVER	0.047619	0.5893866812539263
EBOLA HEMORRHAGIC FEVER	0.047619	0.5893866812539263
LYMPHOKINE DEFICIENCY	0.047619	0.5893866812539263
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.047619	0.5893866812539263
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.047619	0.5893866812539263
LASSA FEVER	0.047619	0.5893866812539263
MARBURG HEMORRHAGIC FEVER	0.047619	0.5893866812539263
MONOCYTE CHEMOTACTIC DISORDER	0.047619	0.5893866812539263
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.047619	0.5893866812539263
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.047619	0.5893866812539263
ADULT-ONSET STILL DISEASE	0.047619	0.5893866812539263
HALLERMANN-STREIFF SYNDROME; HSS	0.04749835	0.5878933801956663
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.047475624	0.5876120974783019
MICROTRIPLICATION 11Q24.1	0.04735926	0.5861718448107232
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04735926	0.5861718448107232
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.047165953999999996	0.5837792708002132
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04700985	0.5818471508797936
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.5693487718045612
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.04592227	0.5683860289159105
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.567705088584197
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	0.5670311042010516
WHIM SYNDROME	0.0456402	0.5648948110998855
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.562596377560566
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.562596377560566
LITHIUM TRANSPORT	0.0454545	0.562596377560566
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.045287384	0.5605279606550361
CD8 DEFICIENCY, FAMILIAL	0.04507352	0.5578809375508196
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	0.553550302596202
HAMAMY SYNDROME; HMMS	0.044678749999999996	0.5529948168813679
8P INVERTED DUPLICATION/DELETION SYNDROME	0.0445462	0.5513542279441748
LYME DISEASE	0.04454545	0.551344945094662
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04448623	0.5506119712971473
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054519
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.044146050000000006	0.5464015183008861
SLC39A8-CDG	0.04367104000000001	0.5405222565049135
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.043627469999999995	0.5399829848338947
COFFIN-LOWRY SYNDROME	0.043570540000000005	0.5392783546702251
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.5381366879515023
JUVENILE XANTHOGRANULOMA	0.043478300000000004	0.5381366879515023
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	0.5381366879515023
EOSINOPHILIA, FAMILIAL	0.043478300000000004	0.5381366879515023
COMMON VARIABLE IMMUNODEFICIENCY	0.043478300000000004	0.5381366879515023
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	0.5381366879515023
COMPLEMENT COMPONENT C1R DEFICIENCY	0.043478300000000004	0.5381366879515023
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.5381366879515023
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA;;IMMOTILE CILIA SYNDROME DUE TO EXCESSIVELY LONG CILIA	0.043478300000000004	0.5381366879515023
HYPOPLASMINOGENEMIA	0.043478300000000004	0.5381366879515023
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	0.5381366879515023
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	0.5381366879515023
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.5381366879515023
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.5381366879515023
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.5381366879515023
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.5381366879515023
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	0.5381366879515023
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.04344788399999999	0.537760225083802
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.04331429	0.5361067144200872
HARTNUP DISEASE	0.043299144	0.5359192503684633
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079055
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04298672	0.5320523370669645
16P13.11 MICRODUPLICATION SYNDROME	0.042791624	0.5296376079889512
KEPPEN-LUBINSKY SYNDROME	0.042768509999999996	0.5293515229441055
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.042621094	0.5275269355524398
OGDEN SYNDROME	0.042527114	0.5263637326228477
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.04250626	0.5261056198978667
FETAL HYDANTOIN SYNDROME	0.042267083999999996	0.5231453068111662
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.5228274125353243
CORNELIA DE LANGE SYNDROME	0.04205355	0.5205023681607354
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.04182724	0.5177012992631403
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.041711279999999996	0.5162660469571656
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	0.5157142743821367
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	0.5157142743821367
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821367
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	0.5157142743821367
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0416666	0.5157130366688685
MYELOLYMPHATIC INSUFFICIENCY	0.0414764	0.5133589060324734
CERNUNNOS-XLF DEFICIENCY	0.0414764	0.5133589060324734
IMMUNE DEFICIENCY DISEASE	0.0414764	0.5133589060324734
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.041419823999999994	0.5126586573737736
MILD CANAVAN DISEASE	0.04140923999999999	0.5125276578014518
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0412597	0.5106767813799665
SHUKLA-VERNON SYNDROME; SHUVER	0.041107003999999996	0.5087868427277321
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264553
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.040634180000000006	0.5029346373438054
WILSON DISEASE	0.0406015	0.5025301526477097
MERCURY POISONING	0.04	0.4950853073386055
TYPHOID	0.04	0.4950853073386055
BUERGER DISEASE	0.04	0.4950853073386055
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.4950853073386055
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.039973369999999994	0.49475570429524474
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.494697903085613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.03975635400000001	0.49206966846881
YOU-HOOVER-FONG SYNDROME; YHFS	0.03975635400000001	0.49206966846881
TRANSKETOLASE DEFICIENCY	0.039720033999999994	0.49162013100974633
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.039648114	0.49072996762715165
HURLER SYNDROME	0.039642994	0.4906665967078123
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.49061716243987447
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.039366054	0.48723887358245344
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.039271904	0.48607356654030526
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.039210800000000004	0.48531727422481485
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.039210800000000004	0.48531727422481485
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039210800000000004	0.48531727422481485
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.4846570779674787
FETAL ALCOHOL SYNDROME	0.039134214	0.48436935914111895
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.039113079999999995	0.4841077808189865
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.039075413999999996	0.4836415837393311
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.48233079587962147
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.48233079587962147
4Q21 MICRODELETION SYNDROME	0.03893063	0.4818495729608884
HYPERPROLINEMIA, TYPE I	0.038901064	0.481483630655969
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.48076328153379133
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.038842864	0.48076328153379133
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.038406873999999994	0.47536697545512735
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.038376214	0.4749874925670523
XQ28 (MECP2) DUPLICATION	0.038337673999999995	0.4745104778734316
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.038220104	0.4730552983838366
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.4712556137831301
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.037762833999999995	0.4673956069216684
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037684344	0.4664241257773433
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.03761906	0.465616097047236
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.03758791399999999	0.4652305988726767
KEUTEL SYNDROME	0.037582614	0.46516500006945444
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0370879	0.45904185925108665
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 41; CILD41	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.037037060000000004	0.4584126058254593
IMMUNODEFICIENCY 20; IMD20	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 27; CILD27	0.037037060000000004	0.4584126058254593
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.037037060000000004	0.4584126058254593
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.036939524	0.45720538981204484
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.036926643999999995	0.45704597234308175
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.036926643999999995	0.45704597234308175
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.036915784	0.4569115566821394
PITUITARY APOPLEXY	0.03680355	0.4555224215725433
BAKER-GORDON SYNDROME; BAGOS	0.036708684	0.4543482525033937
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.036559194	0.45249799493854254
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.036558089999999994	0.4524843305840599
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.036547913999999994	0.4523583808818729
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.036487714	0.4516132774943284
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.03643054	0.450905627310284
2Q37 MICRODELETION SYNDROME	0.036427664	0.45087003067668635
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774	0.44979458161782004
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03627531	0.4489843250038297
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	0.44879302404107413
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.44879302404107413
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.036157744	0.44752919502276545
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.036116034	0.4470129448185381
COFS SYNDROME	0.03597881	0.44531450516318233
CLASSIC HOMOCYSTINURIA	0.035857700000000006	0.4438155106238879
OCHOA SYNDROME	0.0357928	0.44301223471273093
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	0.442040629797079
ZELLWEGER SYNDROME	0.035714300000000004	0.442040629797079
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	0.442040629797079
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.442040629797079
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	0.442040629797079
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	0.442040629797079
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0357143	0.44204062979707887
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.44159109233801547
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664553999999994	0.44142491695460717
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035513753999999995	0.43955844534594063
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.43938301186728534
CUSHING SYNDROME	0.035376540000000005	0.43786012946191183
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.035335934	0.43735754361216694
CHOREOACANTHOCYTOSIS	0.03531859	0.4371428746229049
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.03531276	0.4370707159393603
ISOTRETINOIN-LIKE SYNDROME	0.03527015	0.43654332631571796
SMITH-MAGENIS SYNDROME	0.03502418	0.433498922989566
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03494899	0.43256828638309625
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.034800074	0.43072513329240536
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.034781493999999996	0.43049516616714656
CHROMOSOME 10Q26 DELETION SYNDROME	0.034750784	0.43011506442243735
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03473354	0.4299016331464437
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.034732544000000004	0.42988930552229104
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.42977865395610076
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.03470841399999999	0.4295906453106389
SHORT SYNDROME	0.034328609999999996	0.4248897608089281
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.034162859999999996	0.42283825106664374
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.034110343999999994	0.42218825356663886
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.033985129999999995	0.42063846327481147
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.42062645745610855
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.033807874	0.4184445422438713
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.033662404	0.4166440407524076
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.033573954	0.4155492833665551
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	0.41467639846118637
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	0.41467639846118637
OCULODENTODIGITAL DYSPLASIA	0.03350343	0.41467639846118637
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440584	0.41389854518056135
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033374334	0.4130785601402817
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.41287701091166423
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.4118305243432772
JOUBERT SYNDROME 1	0.033062694000000004	0.4092213505108067
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03302721	0.40878216033466663
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.40864143233605554
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.032994344	0.4083753734918919
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.4060151780604818
DISTAL MONOSOMY 10Q	0.032783364	0.4057640460383344
FRAGILE X SYNDROME	0.03276267	0.4055079136545827
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534615
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.03254796399999999	0.40285046900464655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.03251714	0.40246895626681156
NEPHRONOPHTHISIS 11; NPHP11	0.032508383999999994	0.402360582093035
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.03245731	0.40172843241835987
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.032431254	0.40140593384915946
AMYLOIDOSIS	0.03242385	0.4013142935587711
SECKEL SYNDROME 2; SCKL2	0.0322581	0.39926278381648667
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.39926278381648667
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	0.39926278381648667
HYPER-BETA-ALANINEMIA	0.0322581	0.39926278381648667
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.39926278381648667
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	0.39926278381648667
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.39926278381648667
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.39926278381648667
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.39926278381648667
SECKEL SYNDROME	0.0322581	0.39926278381648667
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.39926278381648667
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.39926278381648667
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	0.39926278381648667
DYSTONIA, JUVENILE-ONSET	0.0322581	0.39926278381648667
COG1-CDG	0.0322581	0.39926278381648667
DEND SYNDROME	0.0322581	0.39926278381648667
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.39926278381648667
DENT DISEASE	0.0322581	0.39926278381648667
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.032233833999999996	0.39896244031478967
HURLER-SCHEIE SYNDROME	0.03216852	0.3981540402707019
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.032131454	0.39769526947065653
WHIPPLE DISEASE	0.03209902	0.39729382954920106
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.032047243999999996	0.39665299112738195
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03204225	0.3965911797267608
AICARDI-GOUTIERES SYNDROME 7	0.032030064	0.3964403519878801
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.03195696	0.39553553408018804
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.39547716352245277
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.031920474000000004	0.3950839420170992
20Q11.2 MICRODUPLICATION SYNDROME	0.031778164	0.3933225522649152
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.031664	0.39190952928924006
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.39113514160576635
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03158345	0.39091255125158697
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03158345	0.39091255125158697
CLASSIC PHENYLKETONURIA	0.031581224	0.3908849997542336
WHIM SYNDROME	0.0315557	0.3905690858196208
SECKEL SYNDROME 9; SCKL9	0.031432074	0.3890389504144947
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.03137492	0.388331547773104
HELSMOORTEL-VAN DER AA SYNDROME	0.031342704	0.3879328060665735
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03133789	0.3878732225498353
2Q23.1 MICRODUPLICATION SYNDROME	0.031320504	0.38765803372100055
TRISOMY 13	0.03121691	0.38637583703778966
MEHMO SYNDROME	0.03121691	0.38637583703778966
15Q11Q13 MICRODUPLICATION SYNDROME	0.031086043999999997	0.3847560911920353
ALSTROM SYNDROME; ALMS	0.031080304	0.3846850464504322
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.031066464000000002	0.38451374693409307
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.3843827473617713
MENTAL RETARDATION, X-LINKED 21	0.031014879999999998	0.38387528492174916
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.03100006	0.38369185581538023
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.03082924	0.38157759401039076
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.38072357185523165
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.38072357185523165
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.030704254	0.38003062570481516
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	0.37944736570423954
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.030657129999999998	0.37944736570423954
COSTELLO SYNDROME; CSTLO	0.030362284	0.3757980176410506
CONGENITAL DISORDER OF GLYCOSYLATION	0.030362284	0.3757980176410506
TETRASOMY X	0.030362284	0.3757980176410506
PENTASOMY X	0.030362284	0.3757980176410506
HARTNUP DISORDER	0.030137654000000003	0.37301774232636387
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.030060534	0.37206321785381496
MENTAL RETARDATION, X-LINKED 98; MRX98	0.030060534	0.37206321785381496
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0300522	0.371960066830031
ISOLATED CEREBELLAR AGENESIS	0.03004853	0.37191464275308267
NEUROFERRITINOPATHY	0.03004853	0.37191464275308267
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.030011443999999998	0.37145562441038366
6Q16 MICRODELETION SYNDROME	0.029968693999999997	0.3709265019881655
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.37078614530353504
NAVAJO NEUROHEPATOPATHY	0.029957354	0.37078614530353504
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.029894513999999997	0.3700083662857061
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.02984282	0.3693685427887671
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.029833174	0.36924915296690236
DOWN SYNDROME	0.02981673	0.36904562339705543
C SYNDROME	0.02981673	0.36904562339705543
QAZI-MARKOUIZOS SYNDROME	0.029649850000000002	0.3669801274948388
LEIGH SYNDROME; LS	0.029644084	0.36690876094778596
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.029644084	0.36690876094778596
MIRAGE SYNDROME; MIRAGE	0.029628754	0.3667190195037484
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.029581304	0.366131724557918
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.36436681970005197
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	0.3640337510595399
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	0.3640337510595399
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	0.3640337510595399
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	0.3640337510595399
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	0.3640337510595399
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	0.3640337510595399
MYELOPEROXIDASE DEFICIENCY	0.0294118	0.3640337510595399
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	0.3640337510595399
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	0.3640337510595399
MONOMELIC AMYOTROPHY	0.0294118	0.3640337510595399
RAGWEED SENSITIVITY	0.0294118	0.3640337510595399
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	0.3640337510595399
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	0.3640337510595399
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	0.3640337510595399
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	0.3640337510595399
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	0.3640337510595399
ECHO VIRUS 11 SENSITIVITY	0.0294118	0.3640337510595399
MYASTHENIA GRAVIS; MG	0.0294118	0.3640337510595399
IMMUNE SUPPRESSION	0.0294118	0.3640337510595399
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0293714	0.3635337148991279
ASPARTYLGLUCOSAMINURIA; AGU	0.02931138	0.36279083939546636
17Q21.31 MICRODUPLICATION SYNDROME	0.029181284	0.3611806239418783
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.029116954	0.360384402996351
PROPIONIC ACIDEMIA	0.029116954	0.360384402996351
ALG1-CDG	0.029116954	0.360384402996351
GALLOWAY-MOWAT SYNDROME	0.029116954	0.360384402996351
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029116954	0.360384402996351
COFFIN-SIRIS SYNDROME 7; CSS7	0.029083903999999994	0.35997533876116233
PROGRESSIVE SUPRANUCLEAR PALSY	0.029076499999999998	0.35988369847077406
CORNELIA DE LANGE SYNDROME 1	0.02901857	0.3591666911744209
WIEACKER-WOLFF SYNDROME	0.028931114	0.3580842366584558
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.028911904	0.3578464719396064
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02873829	0.3556976284258993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870539
ADIPOSIS DOLOROSA	0.028665130000000004	0.35479211739877703
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.35363200875235584
DYSOSTEOSCLEROSIS	0.0285714	0.35363200875235584
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	0.35363200875235584
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	0.35363200875235584
ALPHA-THALASSEMIA	0.0285714	0.35363200875235584
CHERUBISM	0.0285714	0.35363200875235584
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.35363200875235584
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.35363200875235584
ACRODYSOSTOSIS	0.0285714	0.35363200875235584
ALG12-CDG	0.0285714	0.35363200875235584
SCHEIE SYNDROME	0.0285714	0.35363200875235584
ACHONDROPLASIA	0.0285714	0.35363200875235584
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.35363200875235584
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	0.35363200875235584
CONGENITAL LOBAR EMPHYSEMA	0.0285714	0.35363200875235584
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.35363200875235584
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	0.35363200875235584
COG7-CDG	0.0285714	0.35363200875235584
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	0.35363200875235584
CHEILITIS GLANDULARIS	0.0285714	0.35363200875235584
TOXIC EPIDERMAL NECROLYSIS	0.028550769999999996	0.3533766685050959
WYBURN-MASON SYNDROME	0.028533564	0.35316370756014426
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.35056191049875307
HEREDITARY FOLATE MALABSORPTION	0.028299204	0.3502630027444473
SALT-AND-PEPPER SYNDROME	0.028297364000000002	0.35024022882030975
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.02824098	0.34954235657108523
HYPERLYSINEMIA, TYPE I	0.02822056	0.3492896155216889
7Q11.23 DUPLICATION SYNDROME	0.02822056	0.3492896155216889
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.3481707227271037
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02798801	0.3464113133161491
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.02798801	0.3464113133161491
COFFIN-SIRIS SYNDROME 8; CSS8	0.02797498	0.34625003927728354
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.027926644	0.3456517781918955
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.027851554	0.3447223792986942
RICHARDS-RUNDLE SYNDROME; RRNS	0.027806824	0.3441687501537628
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.027777800000000002	0.3438095162547579
CILIARY DYSKINESIA, PRIMARY, 24; CILD24	0.027777800000000002	0.3438095162547579
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.027777800000000002	0.3438095162547579
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.027777800000000002	0.3438095162547579
%120050 COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S;;CB3S	0.027777800000000002	0.3438095162547579
IMMUNODEFICIENCY 24	0.027777800000000002	0.3438095162547579
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.027777800000000002	0.3438095162547579
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.3438095162547579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.027751810000000002	0.34348783457631465
RABSON-MENDENHALL SYNDROME	0.027665164	0.34241540553782307
MENTAL RETARDATION, X-LINKED 104; MRX104	0.027570624000000002	0.3412452714139283
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.02740662	0.3392153721453093
SCIMITAR SYNDROME	0.02740662	0.3392153721453093
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.3375584453929738
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.336308231220617
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.02711961	0.335663011293828
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.335663011293828
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.02711961	0.335663011293828
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248825
MAN1B1-CDG	0.026818604	0.33193742009330884
SARCOSINEMIA	0.026581164	0.3289985937089469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.026564034000000004	0.3287865734260792
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.026554979999999995	0.32867451086676297
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518482
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518482
ALG13-CDG	0.02649091	0.3278815079757334
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.026345814000000002	0.3260856355318934
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.32571414827153183
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.32571414827153183
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.32571414827153183
ALZHEIMER DISEASE 3; AD	0.0263158	0.32571414827153183
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.32571414827153183
ALZHEIMER DISEASE 10	0.0263158	0.32571414827153183
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.32571414827153183
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.02631175	0.3256640208841638
BARATELA-SCOTT SYNDROME	0.026295664	0.3254649223278176
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.32407813887343145
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0260899	0.32291815399833707
JUVENILE MYOCLONIC EPILEPSY	0.02601594	0.322002741265068
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.025992634	0.3217142798107472
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.025960614	0.32131796402222257
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.3210901752723161
DISTAL TRISOMY 5Q	0.02571426	0.3182688078771202
DISTAL TRISOMY 6P	0.025600384	0.316859349515658
RETT SYNDROME	0.02557119	0.3164980115040969
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.3161807113306236
OROFACIODIGITAL SYNDROME TYPE 4	0.025419274	0.31461772701535556
PEHO SYNDROME	0.025419274	0.31461772701535556
DUBOWITZ SYNDROME	0.025326019999999998	0.3134635098840917
AGEL AMYLOIDOSIS	0.02527774	0.31286594191813405
BILATERAL POLYMICROGYRIA	0.025210594000000003	0.3120348669669701
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.02518961	0.31177514521474026
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.025189414	0.3117727192967343
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.3111679725938202
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.025112464	0.3108202989367417
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02510348	0.3107091027767134
CEREBROFACIOTHORACIC DYSPLASIA	0.02505483	0.3101069552716628
FREEMAN-SHELDON SYNDROME	0.02505483	0.3101069552716628
6P22 MICRODELETION SYNDROME	0.02505483	0.3101069552716628
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02502158	0.30969541560993763
SCHIZOPHRENIA 4	0.025	0.30942831708662843
SCHIZOPHRENIA 19; SCZD19	0.025	0.30942831708662843
SCHIZOPHRENIA 15; SCZD15	0.025	0.30942831708662843
MONILETHRIX	0.025	0.30942831708662843
HYPERPROLINEMIA TYPE 1	0.025	0.30942831708662843
MYOPATHY AND DIABETES MELLITUS	0.025	0.30942831708662843
MADRAS MOTOR NEURON DISEASE	0.025	0.30942831708662843
ACATALASEMIA	0.025	0.30942831708662843
CYSTINOSIS	0.024953649999999997	0.3088546369867498
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.3088546369867498
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.3088546369867498
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.024939354	0.308677693497907
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02487372	0.3078653327713604
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.02485322	0.3076116015513494
19P13.3 MICRODUPLICATION SYNDROME	0.024837964	0.30742277601513046
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.024800864000000002	0.30696358439257393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.30696358439257393
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.02476118	0.3064724102591633
TRISOMY 18P	0.02469528	0.3056567572153229
WHITE-SUTTON SYNDROME; WHSUS	0.024647314	0.30506307566902785
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	0.30430604072557643
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.024553453999999995	0.3039013579953577
16P11.2P12.2 MICRODELETION SYNDROME	0.024528943999999997	0.30359799447328606
CLEIDOCRANIAL DYSPLASIA	0.024430419999999998	0.3023785498527803
VASCULAR EHLERS-DANLOS SYNDROME	0.024390903999999998	0.3018894550776605
SULFOCYSTEINURIA	0.024355054	0.3014457348709583
DISTAL MONOSOMY 9P	0.024355054	0.3014457348709583
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.3014457348709583
GERODERMA OSTEODYSPLASTICA	0.024355054	0.3014457348709583
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.024355054	0.3014457348709583
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.3014457348709583
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.3014457348709583
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.3002111901485788
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.024193434	0.2994453426866567
SCLERODERMA	0.024156530000000002	0.29898857698210607
GAUCHER DISEASE, PERINATAL LETHAL	0.023972629999999998	0.2967124222816168
SICKLE CELL ANEMIA	0.02395281	0.2964671075118306
ROIFMAN SYNDROME; RFMN	0.023889314	0.29568120909496126
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02382682	0.2949077125650408
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.2946933406269632
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0238095	0.2946933406269632
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.2946933406269632
BRITTLE CORNEA SYNDROME	0.0238095	0.2946933406269632
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.2946933406269632
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0238095	0.2946933406269632
HURLER-SCHEIE SYNDROME	0.0238095	0.2946933406269632
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.2946933406269632
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0238095	0.2946933406269632
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0238095	0.2946933406269632
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0238095	0.2946933406269632
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0238095	0.2946933406269632
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0238095	0.2946933406269632
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.2946933406269632
SIALIDOSIS TYPE 1	0.0238095	0.2946933406269632
NON-DISTAL TRISOMY 13Q	0.0238095	0.2946933406269632
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.2946933406269632
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023726913999999998	0.29367116274716654
JOUBERT SYNDROME 30; JBTS30	0.023726913999999998	0.29367116274716654
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.023343759999999998	0.2889288148509661
ROIFMAN SYNDROME	0.023343759999999998	0.2889288148509661
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.023293854	0.2883111216672651
KLEEFSTRA SYNDROME 2; KLEFS2	0.023246224	0.28772159883755166
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023181359999999998	0.2869187685031714
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.022917634	0.28365459680909183
2P15P16.1 MICRODELETION SYNDROME	0.022811544	0.28234150680270304
TAY-SACHS DISEASE; TSD	0.0227273	0.2812988076369172
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.2812988076369172
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.2812988076369172
CAUDAL REGRESSION SEQUENCE	0.0227273	0.2812988076369172
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.2812988076369172
MEHMO SYNDROME; MEHMO	0.022720683999999998	0.28121692052708336
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.022624184	0.280022527223129
LOWRY-MACLEAN SYNDROME	0.02261456	0.27990340969818334
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.0225934	0.2796415095706012
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.022586794	0.2795597462320943
MOEBIUS SYNDROME; MBS	0.02257444	0.27940683913492276
CUTIS LAXA	0.022539324	0.27897220374361015
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.022473180000000002	0.2781535306793951
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02243237	0.27764841989458283
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.02240255	0.2772793337979619
CK SYNDROME	0.022392773999999997	0.2771583349488483
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.022392773999999997	0.2771583349488483
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.2734028158415006
CROUZON SYNDROME	0.02207863	0.27327013297913383
SAETHRE-CHOTZEN SYNDROME	0.02207863	0.27327013297913383
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.27215260166914385
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.27215260166914385
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.27215260166914385
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.021822154	0.27009569549700946
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021822154	0.27009569549700946
CEDNIK SYNDROME	0.021822154	0.27009569549700946
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	0.27009569549700946
DYSTONIA 28, CHILDHOOD-ONSET	0.021822154	0.27009569549700946
PYRUVATE DEHYDROGENASE DEFICIENCY	0.021822154	0.27009569549700946
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.27009569549700946
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.27009569549700946
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.021757704	0.26929798929556015
PORPHYRIA	0.02173918	0.26906871528973164
ALPHA-MANNOSIDOSIS	0.021647524	0.26793427681649595
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.021585954	0.267172216757175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.021585954	0.267172216757175
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.021585954	0.267172216757175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.021585954	0.267172216757175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.021585954	0.267172216757175
INFANT BOTULISM	0.021532080000000002	0.266505411110986
ATAXIA-TELANGIECTASIA	0.021509149999999998	0.2662216034585541
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.021418750000000004	0.26510271066396895
TYSHCHENKO SYNDROME	0.021378854	0.26460891257842933
OROFACIODIGITAL SYNDROME TYPE 14	0.021378854	0.26460891257842933
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.26414613158739464
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530143
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.2633433012530143
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0212766	0.2633433012530143
X-LINKED RETINOSCHISIS	0.0212766	0.2633433012530143
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.2633433012530143
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530143
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530143
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.2633433012530143
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0212766	0.2633433012530143
RAVINE SYNDROME	0.0212766	0.2633433012530143
3MC SYNDROME 1	0.0212766	0.2633433012530143
PRIMARY BASILAR INVAGINATION	0.0212766	0.2633433012530143
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.2633433012530143
JUVENILE ABSENCE EPILEPSY	0.0212766	0.2633433012530143
KURU, SUSCEPTIBILITY TO	0.0212766	0.2633433012530143
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530143
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.2633433012530143
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.02127535	0.26332782983715997
CUTANEOUS MASTOCYTOSIS	0.02127535	0.26332782983715997
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.021234193999999998	0.26281843656443926
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021215234	0.26258376612876083
TEMPLE SYNDROME	0.021135559999999998	0.26159763045933837
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.2613925908793041
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.021062764	0.2606966247085129
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.020976494	0.25962884947191034
NEPHROGENIC DIABETES INSIPIDUS	0.020953753999999998	0.25934739347468827
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.25934739347468827
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.020953753999999998	0.25934739347468827
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.25934739347468827
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.02086915	0.25830023854113643
MORQUIO SYNDROME A	0.02086915	0.25830023854113643
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.02086915	0.25830023854113643
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.02086915	0.25830023854113643
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.25785651833443424
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.25785651833443424
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.25785651833443424
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.25785651833443424
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.25785651833443424
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.25785651833443424
APNEA, CENTRAL SLEEP	0.0208333	0.25785651833443424
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.25785651833443424
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.25785651833443424
UNIQUE GREEN PHENOMENON	0.0208333	0.25785651833443424
DERMOIDS OF CORNEA	0.0208333	0.25785651833443424
611426 TENTED EYEBROWS	0.0208333	0.25785651833443424
INFANTILE MYOFIBROMATOSIS	0.0208333	0.25785651833443424
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.25785651833443424
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.25785651833443424
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.25785651833443424
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.25785651833443424
GLAUCOMA - SLEEP APNEA	0.0208333	0.25785651833443424
IMINOGLYCINURIA	0.0208333	0.25785651833443424
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.25785651833443424
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.25785651833443424
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.25785651833443424
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.25785651833443424
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.25785651833443424
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.25785651833443424
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.25785651833443424
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.25785651833443424
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.25785651833443424
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.25785651833443424
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.25785651833443424
GAUCHER DISEASE, TYPE I	0.0208333	0.25785651833443424
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.25785651833443424
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.25785651833443424
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.25785651833443424
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.25785651833443424
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.25785651833443424
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.25785651833443424
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.25785651833443424
PUPIL, EGG-SHAPED	0.0208333	0.25785651833443424
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.25785651833443424
HYPOCHONDROPLASIA	0.0208333	0.25785651833443424
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.25785651833443424
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.25785651833443424
CRANDALL SYNDROME	0.0208333	0.25785651833443424
STICKLER SYNDROME, TYPE III	0.0208333	0.25785651833443424
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.25785651833443424
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.25785651833443424
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.25785651833443424
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.25785651833443424
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.25785651833443424
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.02079591	0.2573937373433995
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020676729999999997	0.25591863067018406
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.25583137188476573
MYHRE SYNDROME	0.020617114	0.25518075552812663
GAUCHER DISEASE, TYPE II	0.020574764	0.2546565839589819
FAMILIAL HYPERALDOSTERONISM TYPE I	0.020408199999999998	0.2525949992306932
PANHYPOPHYSITIS	0.020408199999999998	0.2525949992306932
TERATOMA, PINEAL	0.020408199999999998	0.2525949992306932
FAMILIAL COLD URTICARIA	0.020408199999999998	0.2525949992306932
PARATHYROID CARCINOMA	0.020408199999999998	0.2525949992306932
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.2525949992306932
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.020408199999999998	0.2525949992306932
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306932
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.2525949992306932
NEPHRONOPHTHISIS 4	0.020408199999999998	0.2525949992306932
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.2525949992306932
NEPHRONOPHTHISIS 1	0.020408199999999998	0.2525949992306932
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.2525949992306932
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.2525949992306932
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.2525949992306932
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.2525949992306932
HELIX SYNDROME; HELIX	0.020408199999999998	0.2525949992306932
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.2525949992306932
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.020407093999999997	0.25258131012194524
ANTISYNTHETASE SYNDROME	0.02026382	0.25080798881385447
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.020061544	0.2483043919231739
REACTIVE ARTHRITIS	0.01993005	0.24667687323809434
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.01993005	0.24667687323809434
HYPOTONIA-CYSTINURIA SYNDROME	0.019776354	0.2447745574531765
CHROMOSOME 18Q DELETION SYNDROME	0.019759299999999997	0.24456347783239266
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.01967875	0.24356649979473954
ANDROGEN INSENSITIVITY SYNDROME	0.01967875	0.24356649979473954
EMANUEL SYNDROME	0.019564074	0.24214713972713053
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01944866	0.24071864533560106
XQ25 MICRODUPLICATION SYNDROME	0.019429454000000002	0.24048093012528246
CHROMOSOME 2Q37 DELETION SYNDROME	0.019369393999999998	0.23973755953631348
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019334784	0.23930918697413878
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.019334784	0.23930918697413878
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.019334784	0.23930918697413878
ISOLATED COMPLEX I DEFICIENCY	0.019334784	0.23930918697413878
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.019334784	0.23930918697413878
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.019334784	0.23930918697413878
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.019329434	0.23924296931428224
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.019245174	0.2382000721143735
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.2380387485669772
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918135
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.23802216320918135
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.23802216320918135
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.23802216320918135
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.23802216320918135
248100 MACROSOMIA ADIPOSA CONGENITA	0.0192308	0.23802216320918135
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.23802216320918135
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.23802216320918135
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.23802216320918135
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.23802216320918135
NETHERTON SYNDROME; NETH	0.019161763999999998	0.23716769547724562
RIFT VALLEY FEVER	0.01903825	0.23563894631098015
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.01900676	0.23524919040277784
GOOD SYNDROME	0.01898172	0.23493926700038384
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.01898172	0.23493926700038384
IMMUNODEFICIENCY 50; IMD50	0.01898172	0.23493926700038384
PRUNE BELLY SYNDROME	0.01898172	0.23493926700038384
SEVERE COMBINED IMMUNODEFICIENCY	0.01898172	0.23493926700038384
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01897984	0.23491599799093899
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.018942954	0.23445945507477667
OCCIPITAL HORN SYNDROME	0.018942204	0.23445017222526407
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.23438873213862335
RUBINSTEIN-TAYBI SYNDROME	0.018892884000000002	0.23383973204131558
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.018616209999999998	0.2304153012332505
CADASIL	0.01852894	0.2293351488639645
TRIMETHYLAMINURIA	0.01852894	0.2293351488639645
JOUBERT SYNDROME 26	0.018402654	0.22777209028590045
BLADDER EXSTROPHY	0.01839665	0.22769777798126892
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.01839665	0.22769777798126892
HOLMES-GANG SYNDROME	0.018327754	0.2268450430479089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.018327754	0.2268450430479089
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.018327754	0.2268450430479089
XP21 MICRODELETION SYNDROME	0.018279394	0.22624648491133653
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.018126554	0.22435476395199572
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.018126554	0.22435476395199572
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.018126554	0.22435476395199572
HEART AND BRAIN MALFORMATION SYNDROME	0.018089454	0.22389557232943919
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.22389557232943919
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.018089454	0.22389557232943919
WILSON-TURNER SYNDROME	0.018089454	0.22389557232943919
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.22389557232943919
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.018089454	0.22389557232943919
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.22389557232943919
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018089454	0.22389557232943919
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.22389557232943919
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01798588	0.22261362318888195
AASE-SMITH SYNDROME	0.01791203	0.22169957194020803
GORLIN SYNDROME	0.01791203	0.22169957194020803
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.017912	0.22169920062622755
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.0178571	0.2210196960419053
LARYNGEAL WEB, FAMILIAL	0.0178571	0.2210196960419053
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0178571	0.2210196960419053
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0178571	0.2210196960419053
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0178571	0.2210196960419053
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0178571	0.2210196960419053
FAMILIAL NASAL ACILIA	0.0178571	0.2210196960419053
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.017841273999999997	0.22082381554005673
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.017834914	0.22074509697618994
UNILATERAL POLYMICROGYRIA	0.01778675	0.22014896475762352
19P13.12 MICRODELETION SYNDROME	0.017780143999999998	0.2200672014191165
DISTAL MONOSOMY 6P	0.017780143999999998	0.2200672014191165
CHROMOSOME 19P13.13 DELETION SYNDROME	0.017780143999999998	0.2200672014191165
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.2192820703844736
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.2192820703844736
HARLEQUIN ICHTHYOSIS	0.01768162	0.21884775679861082
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017647554	0.2184261173966159
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.017636304	0.21828687465392688
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01761532	0.2180271529016971
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01761532	0.2180271529016971
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01761532	0.2180271529016971
POSTORGASMIC ILLNESS SYNDROME	0.01760606	0.21791254065304821
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.017581	0.21760236970800056
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.21741998028077697
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.21741998028077697
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544403
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544403
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	0.21714317808544403
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544403
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544403
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544403
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.21675676400306626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.017479994	0.21635220504417446
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017463274	0.21614525938570697
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.21611444032532515
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.21611444032532515
1Q41Q42 MICRODELETION SYNDROME	0.01742467	0.21566745255559447
PRIMARY CILIARY DYSKINESIA	0.017406679999999997	0.21544478793861888
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094000000004	0.21453400425297353
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.017295719999999997	0.21407142129606158
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.017286104	0.21395240278817745
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.017256203999999997	0.2135823265209418
MYOPATHY, CONGENITAL	0.0172414	0.21339909544869584
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.21339909544869584
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.21339909544869584
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.21339909544869584
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.21339909544869584
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.21339909544869584
THUMBS, CONGENITAL CLASPED	0.0172414	0.21339909544869584
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.21339909544869584
269800 SENILE PLAQUE FORMATION	0.0172414	0.21339909544869584
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.21339909544869584
CARDIAC ARRHYTHMIA	0.0172414	0.21339909544869584
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.21339909544869584
CERVICAL RIB	0.0172414	0.21339909544869584
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.21339909544869584
TRANSSEXUALITY	0.0172414	0.21339909544869584
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.21339909544869584
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.21339909544869584
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.21339909544869584
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.21339909544869584
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.21339909544869584
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.21339909544869584
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.21339909544869584
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.21339909544869584
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.21339909544869584
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.21339909544869584
PALMOMENTAL REFLEX	0.0172414	0.21339909544869584
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.21339909544869584
DIASTEMATOMYELIA	0.0172414	0.21339909544869584
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.21339909544869584
JUMPING FRENCHMAN OF MAINE	0.0172414	0.21339909544869584
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.21339909544869584
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.21339909544869584
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.21339909544869584
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.21339909544869584
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.21339909544869584
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.21339909544869584
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.21339909544869584
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.21339909544869584
ERYTHERMALGIA, PRIMARY	0.0172414	0.21339909544869584
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.21339909544869584
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.21339909544869584
MOSAIC TRISOMY 15	0.0172414	0.21339909544869584
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.21339909544869584
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.21339909544869584
MOTION SICKNESS	0.0172414	0.21339909544869584
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.21339909544869584
HOYERAAL-HREIDARSSON SYNDROME	0.017212254	0.2130383515395035
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.2130383515395035
FANCONI ANEMIA	0.017175484	0.21258324437073256
CONGENITAL HYPOTHYROIDISM	0.017162484000000002	0.2124223416458475
TENORIO SYNDROME; TNORS	0.01714017	0.21214615830714864
EHLERS-DANLOS SYNDROME, TYPE VI	0.01709655	0.21160626777949587
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.017020709999999998	0.21066758603678187
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026914
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.016762159999999998	0.20746747838147195
ACHROMATOPSIA	0.01674055	0.2072000085441823
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.016736014	0.20714386587033012
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016736014	0.20714386587033012
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.20679341973553045
LANDAU-KLEFFNER SYNDROME	0.016686724	0.2065337970003621
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	0.2062859572955084
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0166667	0.2062859572955084
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.2062859572955084
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.2062859572955084
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.2062859572955084
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.2062859572955084
117600 CEREBRAL SARCOMA	0.0166667	0.2062859572955084
PITYRIASIS RUBRA PILARIS	0.0166667	0.2062859572955084
ONCOCYTOMA	0.0166667	0.2062859572955084
ICHTHYOSIS, X-LINKED	0.0166667	0.2062859572955084
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.2062859572955084
HURIEZ SYNDROME; HRZ	0.0166667	0.2062859572955084
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.2062859572955084
N SYNDROME	0.0166667	0.2062859572955084
NASOPHARYNGEAL CARCINOMA	0.0166667	0.2062859572955084
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.2062859572955084
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.2062859572955084
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0166667	0.2062859572955084
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.2062859572955084
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.2062859572955084
THYMOMA, FAMILIAL	0.0166667	0.2062859572955084
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.2062859572955084
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.2062859572955084
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0166667	0.2062859572955084
CHYLOUS ASCITES	0.0166667	0.2062859572955084
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.2062859572955084
ACQUIRED PURPURA FULMINANS	0.0166667	0.2062859572955084
PHEOCHROMOCYTOMA	0.0166667	0.2062859572955084
ADAMANTINOMA OF LONG BONES	0.0166667	0.2062859572955084
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.2062859572955084
HAND-FOOT-GENITAL SYNDROME	0.01662993	0.2058308501267374
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.01662993	0.2058308501267374
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185235
ANGELMAN SYNDROME	0.016525810000000002	0.20454214307173502
MUENKE SYNDROME	0.016514624	0.20440369246553775
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062447
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.016266514000000003	0.20133280207544324
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.016237154	0.20096940945985667
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.016237154	0.20096940945985667
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.01619046	0.20039147162633497
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01619046	0.20039147162633497
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.01619046	0.20039147162633497
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.19963077305160917
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01608196	0.19904855273017896
NETHERTON SYNDROME	0.016047474	0.19862171493245698
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.016047474	0.19862171493245698
IMMUNODEFICIENCY 23; IMD23	0.016047474	0.19862171493245698
17Q12 MICRODUPLICATION SYNDROME	0.015989259999999998	0.19790119253042174
MEIER-GORLIN SYNDROME 3; MGORS3	0.015989259999999998	0.19790119253042174
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01597067	0.19767110163383617
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.015930154	0.19716962972603286
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.015930154	0.19716962972603286
EVEN-PLUS SYNDROME	0.015930154	0.19716962972603286
JOUBERT SYNDROME 35; JBTS35	0.015930154	0.19716962972603286
CURRARINO SYNDROME	0.015930154	0.19716962972603286
611961 STEVENSON-CAREY SYNDROME	0.015930154	0.19716962972603286
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01588199	0.19657349750746644
HEREDITARY METHEMOGLOBINEMIA	0.01588199	0.19657349750746644
RING CHROMOSOME 7 SYNDROME	0.01588199	0.19657349750746644
DISTAL MONOSOMY 15Q	0.015871534	0.19644408220812815
ASPARTYLGLUCOSAMINURIA	0.01576031	0.19506744800254242
CHROMOSOME 16P13.3 DELETION SYNDROME	0.015748674	0.19492342768663765
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.01573813	0.19479292319962316
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.015731544	0.19471140740376988
MARFAN SYNDROME	0.01572291	0.19460454324018084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.015679574	0.1940681678182102
3P25.3 MICRODELETION SYNDROME	0.01567239	0.1939792504970122
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01565682	0.1937865385411306
BARDET-BIEDL SYNDROME 1; BBS1	0.015600443999999998	0.19308876530896757
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.015596684	0.19304222729007775
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.015596684	0.19304222729007775
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015544544	0.1923968835919619
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01553103	0.19222961902087754
AORTIC ARCH DEFECTS	0.015501919999999999	0.19186932068846185
PRIMARY PULMONARY HYPOPLASIA	0.015501919999999999	0.19186932068846185
WEAVER SYNDROME	0.015479624	0.19159336013815134
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.0153846	0.19041723548203776
HARDIKAR SYNDROME	0.0153846	0.19041723548203776
UROFACIAL SYNDROME 2	0.0153846	0.19041723548203776
POLYCYSTIC KIDNEY DISEASE 2	0.0153846	0.19041723548203776
SCALP-EAR-NIPPLE SYNDROME	0.0153846	0.19041723548203776
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.0153846	0.19041723548203776
HINMAN SYNDROME	0.0153846	0.19041723548203776
CONGENITAL PRIMARY MEGAURETER	0.0153846	0.19041723548203776
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0153846	0.19041723548203776
UROFACIAL SYNDROME	0.0153846	0.19041723548203776
109820 BLADDER DIVERTICULUM	0.0153846	0.19041723548203776
PRIMARY HYPEROXALURIA TYPE 2	0.0153846	0.19041723548203776
PRIMARY HYPEROXALURIA TYPE 1	0.0153846	0.19041723548203776
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0153846	0.19041723548203776
SMALL CELL CARCINOMA OF THE BLADDER	0.0153846	0.19041723548203776
POSTERIOR URETHRAL VALVE	0.0153846	0.19041723548203776
VESICOURETERAL REFLUX 8; VUR8	0.0153846	0.19041723548203776
CONGENITAL MEGACALYCOSIS	0.0153846	0.19041723548203776
TRISOMY X	0.015380584	0.19036752891718095
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01532983	0.18973933992496433
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.18936139180134204
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.015213704000000002	0.18830203301496432
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.015213704000000002	0.18830203301496432
LOEYS-DIETZ SYNDROME 3; LDS3	0.015207150000000001	0.18822091328735685
LOEYS-DIETZ SYNDROME 5	0.015207150000000001	0.18822091328735685
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01520312	0.1881710334426425
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01518599	0.18795901315977473
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01493168	0.1848113845470427
CLASSICAL EHLERS-DANLOS SYNDROME	0.014916849999999999	0.18462783166934693
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017305
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017305
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01470287	0.18197937281773904
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014664374	0.18150290271795638
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.014645414	0.1812682322822779
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014645414	0.1812682322822779
SALLA DISEASE	0.014645414	0.1812682322822779
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.014645414	0.1812682322822779
CEREBROFACIOARTICULAR SYNDROME	0.014630054	0.18107811952425987
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.014630054	0.18107811952425987
PETTIGREW SYNDROME	0.014630054	0.18107811952425987
XQ25 DUPLICATION SYNDROME	0.014622804	0.1809883853123047
PIERPONT SYNDROME	0.014599554	0.18070061697741419
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.014503344000000001	0.179509813041938
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.179509813041938
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.014498514000000002	0.17945003149107688
MAPLE SYRUP URINE DISEASE; MSUD	0.0144928	0.17937930855492354
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492354
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492354
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492354
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.014451974	0.1788739997359884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014451974	0.1788739997359884
NIEMANN-PICK DISEASE, TYPE A	0.014451974	0.1788739997359884
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.014351354	0.17762861264537813
MENTAL RETARDATION, X-LINKED 91; MRX91	0.014351354	0.17762861264537813
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.014351354	0.17762861264537813
MACROCEPHALY/AUTISM SYNDROME	0.014299214000000001	0.17698326894726227
TIMOTHY SYNDROME; TS	0.014299214000000001	0.17698326894726227
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.014297614	0.1769634655349687
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.17685226937494045
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.17681600437617792
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0142857	0.17681600437617792
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0142857	0.17681600437617792
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.17681600437617792
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.17681600437617792
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.014244153999999998	0.17630178402171065
AMISH LETHAL MICROCEPHALY	0.01411882	0.17475050847396126
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01411882	0.17475050847396126
2Q24 MICRODELETION SYNDROME	0.01411882	0.17475050847396126
MELNICK-NEEDLES SYNDROME	0.01410171	0.17453873573374717
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01409986	0.17451583803828274
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0140845	0.17432572528026472
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.17432572528026472
PULMONARY BLASTOMA	0.0140845	0.17432572528026472
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.17432572528026472
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0140845	0.17432572528026472
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.17432572528026472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0140845	0.17432572528026472
CRANIOECTODERMAL DYSPLASIA 4	0.0140845	0.17432572528026472
ROWLEY-ROSENBERG SYNDROME	0.0140845	0.17432572528026472
TRACHEOPATHIA OSTEOPLASTICA	0.0140845	0.17432572528026472
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	0.17432572528026472
MASP2 DEFICIENCY	0.0140845	0.17432572528026472
AICARDI SYNDROME; AIC	0.0140845	0.17432572528026472
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.17432572528026472
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.17432572528026472
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.014059314000000002	0.17401399481649898
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.014004943999999998	0.17334105011249895
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014004943999999998	0.17334105011249895
FOLATE MALABSORPTION, HEREDITARY	0.013968374	0.17288841837026467
SILVER-RUSSELL SYNDROME	0.013957790000000001	0.17275741879794287
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310085
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.013866904	0.17163251071687344
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0138058	0.170876218401383
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013753660000000001	0.17023087470326712
CYCLIC VOMITING SYNDROME	0.01375206	0.17021107129097357
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.013698599999999998	0.1695493897777155
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.013698599999999998	0.1695493897777155
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.013698599999999998	0.1695493897777155
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.013698599999999998	0.1695493897777155
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013698599999999998	0.1695493897777155
NEUTROPHIL ACTIN DYSFUNCTION	0.013698599999999998	0.1695493897777155
GRISCELLI SYNDROME, TYPE 2; GS2	0.013698599999999998	0.1695493897777155
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.013698599999999998	0.1695493897777155
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.013698599999999998	0.1695493897777155
COMPLEMENT FACTOR H DEFICIENCY	0.013698599999999998	0.1695493897777155
GLYCOGEN STORAGE DISEASE IB	0.013698599999999998	0.1695493897777155
INFANTILE SYSTEMIC HYALINOSIS	0.013698599999999998	0.1695493897777155
SPECIFIC GRANULE DEFICIENCY	0.013698599999999998	0.1695493897777155
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.013698599999999998	0.1695493897777155
IMMUNODEFICIENCY 33	0.013698599999999998	0.1695493897777155
SICKLE CELL ANEMIA	0.013698599999999998	0.1695493897777155
IMMUNODEFICIENCY 47	0.013698599999999998	0.1695493897777155
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01359558	0.16827429756866494
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.1663539854328253
STURGE-WEBER SYNDROME	0.013421220000000001	0.166116220713976
MICROFORM HOLOPROSENCEPHALY	0.013150129999999998	0.16276090381481537
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.013052284	0.16154985089026908
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026908
IMMUNODEFICIENCY 53; IMD53	0.01285638	0.1591251210890475
COFFIN-SIRIS SYNDROME 6; CSS6	0.012840904	0.15893357258363822
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.012759613999999999	0.15792743546779933
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.012759613999999999	0.15792743546779933
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.012759613999999999	0.15792743546779933
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.012740654	0.15769276503212085
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.15769276503212085
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.012740654	0.15769276503212085
CRANIOFRONTONASAL SYNDROME; CFNS	0.012740654	0.15769276503212085
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.012740654	0.15769276503212085
ELEJALDE DISEASE	0.012740654	0.15769276503212085
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.15769276503212085
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.15769276503212085
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.012617254000000001	0.15616542685898124
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.15587456424091983
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.012593754000000002	0.15587456424091983
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.15587456424091983
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.15587456424091983
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012516634000000002	0.154920039768371
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012516634000000002	0.154920039768371
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.012516634000000002	0.154920039768371
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.15479745664627395
TUBEROUS SCLEROSIS-1	0.01250673	0.15479745664627395
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627395
15Q14 MICRODELETION SYNDROME	0.012504614	0.15477126663351573
MENTAL RETARDATION, X-LINKED 90	0.012467574	0.15431281763892019
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012450353999999999	0.15409968341411087
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012450353999999999	0.15409968341411087
OCULO-PALATO-CEREBRAL SYNDROME	0.012450353999999999	0.15409968341411087
LOCKED-IN SYNDROME	0.012369050000000001	0.15309337301841447
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.012369050000000001	0.15309337301841447
FAMILIAL DYSAUTONOMIA	0.012369050000000001	0.15309337301841447
PELIZAEUS-MERZBACHER DISEASE	0.012369050000000001	0.15309337301841447
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.15184798592780419
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.1509403707881257
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.1509403707881257
CATARACT 48; CTRCT48	0.0121951	0.1509403707881257
RHYNS SYNDROME; RHYNS	0.0121951	0.1509403707881257
LELIS SYNDROME	0.0121951	0.1509403707881257
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0121951	0.1509403707881257
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.1509403707881257
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0121951	0.1509403707881257
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.1509403707881257
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.1509403707881257
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.1509403707881257
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.1509403707881257
FACIOCARDIOMELIC SYNDROME	0.0121951	0.1509403707881257
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0121951	0.1509403707881257
OROFACIODIGITAL SYNDROME TYPE 3	0.0121951	0.1509403707881257
JUBERG-MARSIDI SYNDROME	0.0121951	0.1509403707881257
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.012173774	0.15067641605651813
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012149239999999999	0.15037275548326196
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012149239999999999	0.15037275548326196
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.012100183999999998	0.1497655828623419
C SYNDROME	0.012100183999999998	0.1497655828623419
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012100183999999998	0.1497655828623419
ADAMS-OLIVER SYNDROME 2; AOS2	0.012100183999999998	0.1497655828623419
GLYCEROL KINASE DEFICIENCY; GKD	0.012100183999999998	0.1497655828623419
MARINESCO-SJOGREN SYNDROME; MSS	0.012100183999999998	0.1497655828623419
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.012100183999999998	0.1497655828623419
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692468
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692468
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692468
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692468
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692468
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692468
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692468
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692468
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692468
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692468
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.012048200000000002	0.14912216999692468
FRIED SYNDROME	0.011996304	0.14847984631918354
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.011996304	0.14847984631918354
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.011971080000000002	0.14816764552437586
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011931484000000001	0.14767756057864134
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.14734728917011575
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.14734728917011575
MASTOCYTOSIS	0.011904799999999998	0.14734728917011575
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.14734728917011575
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	0.14734728917011575
YAO SYNDROME	0.011904799999999998	0.14734728917011575
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.14734728917011575
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.14734728917011575
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.14734728917011575
BERNARD-SOULIER SYNDROME	0.011904799999999998	0.14734728917011575
CARCINOID SYNDROME	0.011904799999999998	0.14734728917011575
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.14734728917011575
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.14734728917011575
STÜVE-WIEDEMANN SYNDROME	0.011904799999999998	0.14734728917011575
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.14734728917011575
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.14734728917011575
CHILBLAIN LUPUS	0.011904799999999998	0.14734728917011575
TRANSALDOLASE DEFICIENCY	0.011904799999999998	0.14734728917011575
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.14734728917011575
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.14734728917011575
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.14734728917011575
ICHTHYOSIS VULGARIS	0.011904799999999998	0.14734728917011575
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.14734728917011575
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.14734728917011575
DERMATITIS, ATOPIC	0.011904799999999998	0.14734728917011575
MYOTONIA PERMANENS	0.011904799999999998	0.14734728917011575
2Q33.1 DELETION SYNDROME	0.011783980000000001	0.14585188399929952
MENKES DISEASE	0.011783980000000001	0.14585188399929952
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.14582230265218601
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.01166479	0.1443766535547573
INTELLECTUAL DISABILITY, WOLFF TYPE	0.01166479	0.1443766535547573
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.1440391291464792
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.011486630000000001	0.14217154359587117
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01145324	0.14175827113557024
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.1417274520751884
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.011450749999999999	0.1417274520751884
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.011449464	0.1417115350825575
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011411294	0.14123909992802963
VICI SYNDROME	0.011389054000000001	0.14096383249714936
CHRONIC GRAFT VERSUS HOST DISEASE	0.01125686	0.13932764981919138
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01124789	0.13921662693902068
MONOSOMY 18P	0.011222244000000001	0.13889920299422057
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.011222244000000001	0.13889920299422057
TEMPLE SYNDROME	0.01116402	0.13817855682085844
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01116402	0.13817855682085844
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.01116402	0.13817855682085844
CLEFT LIP/PALATE	0.01116402	0.13817855682085844
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683456
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01115462	0.1380622117736339
KABUKI SYNDROME 1	0.011050144	0.13676909845939617
PELGER-HUET ANOMALY; PHA	0.011050144	0.13676909845939617
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.010965014	0.1357154331540528
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.010942024	0.13543088287365992
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010942024	0.13543088287365992
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.010942024	0.13543088287365992
CHROMOSOME 5Q12 DELETION SYNDROME	0.010924894000000001	0.1352188625907922
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010924894000000001	0.1352188625907922
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.010924894000000001	0.1352188625907922
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.010924894000000001	0.1352188625907922
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.010924894000000001	0.1352188625907922
PMM2-CDG	0.010924894000000001	0.1352188625907922
HAREL-YOON SYNDROME; HAYOS	0.010924894000000001	0.1352188625907922
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.010924894000000001	0.1352188625907922
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.01090391	0.13495914083856234
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01090391	0.13495914083856234
HALL-RIGGS SYNDROME	0.01090391	0.13495914083856234
TEMPLE-BARAITSER SYNDROME	0.01090391	0.13495914083856234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01090391	0.13495914083856234
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01090391	0.13495914083856234
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01090391	0.13495914083856234
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.01090391	0.13495914083856234
WARBURG MICRO SYNDROME 2; WARBM2	0.01090391	0.13495914083856234
ALLAN-HERNDON-DUDLEY SYNDROME	0.01090391	0.13495914083856234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.01090391	0.13495914083856234
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.010854853999999999	0.13435196821764225
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.010854853999999999	0.13435196821764225
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.13435196821764225
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.13435196821764225
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.13435196821764225
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.010854853999999999	0.13435196821764225
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.13435196821764225
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.13435196821764225
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.13435196821764225
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.13435196821764225
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.13435196821764225
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.13435196821764225
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.13435196821764225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.13435196821764225
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.13435196821764225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.13435196821764225
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.010854853999999999	0.13435196821764225
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.13435196821764225
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.13435196821764225
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.13435196821764225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.13435196821764225
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.13435196821764225
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.13435196821764225
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.13435196821764225
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.13435196821764225
GENITOPATELLAR SYNDROME; GTPTS	0.010854853999999999	0.13435196821764225
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.13435196821764225
PROPIONIC ACIDEMIA	0.010854853999999999	0.13435196821764225
REVESZ SYNDROME	0.010854853999999999	0.13435196821764225
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010854853999999999	0.13435196821764225
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.010854853999999999	0.13435196821764225
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.13435196821764225
ARIMA SYNDROME	0.010854853999999999	0.13435196821764225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.13435196821764225
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.13435196821764225
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010854853999999999	0.13435196821764225
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.13435196821764225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.13435196821764225
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.13435196821764225
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.13435196821764225
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.13435196821764225
KRABBE DISEASE	0.010854084	0.134342437825476
INFANTILE DYSTONIA-PARKINSONISM	0.010753464	0.13309705073486575
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.010753464	0.13309705073486575
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010753464	0.13309705073486575
COFFIN-SIRIS SYNDROME 5	0.010753464	0.13309705073486575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010753464	0.13309705073486575
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.010753464	0.13309705073486575
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.010753464	0.13309705073486575
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010753464	0.13309705073486575
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.010753464	0.13309705073486575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.010753464	0.13309705073486575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.010737894	0.1329043387789842
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.13214680875022541
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.01053875	0.1304395070678682
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.01050459	0.13001670421540104
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.01050459	0.13001670421540104
SPINOCEREBELLAR ATAXIA TYPE 27	0.010429109999999998	0.12908247824045307
MONOSOMY 5P	0.01041946	0.12896303891005767
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.010407053999999999	0.1288094882019866
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010407053999999999	0.1288094882019866
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010407053999999999	0.1288094882019866
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01037934	0.12846646834679704
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01037934	0.12846646834679704
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01037934	0.12846646834679704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.1275995739736471
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.1275995739736471
PIERSON SYNDROME	0.010309299999999999	0.1275995739736471
HYPOPHOSPHATASIA, INFANTILE	0.01030853	0.12759004358148088
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.010269014	0.12710094880636105
SYNDROMIC DIARRHEA	0.010269014	0.12710094880636105
OGDEN SYNDROME; OGDNS	0.010269014	0.12710094880636105
AARSKOG-SCOTT SYNDROME	0.010267413999999999	0.12708114539406748
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010265464	0.12705700998533476
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01025843	0.12696994923403926
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.010211004	0.12638295133939323
16Q24.3 MICRODELETION SYNDROME	0.01019234	0.12615194453498904
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01001726	0.12398495614476797
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.12398495614476797
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01001726	0.12398495614476797
NANCE-HORAN SYNDROME	0.01001726	0.12398495614476797
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984135
COG5-CDG	0.009861499999999999	0.12205709395799143
5Q14.3 MICRODELETION SYNDROME	0.009861499999999999	0.12205709395799143
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009857724	0.12201035790497868
MUCOLIPIDOSIS IV; ML4	0.009832834000000002	0.12170229107248726
LARSEN-LIKE SYNDROME	0.009804814	0.12135548381469655
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00972346	0.12034855456236591
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.009696694	0.1200172682289603
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.009607154	0.11890901976848282
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009492564	0.11749072413428456
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.009492564	0.11749072413428456
MENTAL RETARDATION, X-LINKED 9	0.009492564	0.11749072413428456
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.009492564	0.11749072413428456
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009492564	0.11749072413428456
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.009492564	0.11749072413428456
PITT-HOPKINS SYNDROME	0.00948117	0.11734969908448915
FABRY DISEASE	0.00937055	0.11598054066704425
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704425
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.11598054066704425
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704425
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704425
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00937055	0.11598054066704425
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704425
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704425
SAGLIKER SYNDROME	0.00937055	0.11598054066704425
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704425
BETA-THALASSEMIA MAJOR	0.00937055	0.11598054066704425
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704425
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704425
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704425
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406349
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406349
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406349
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406349
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.11532373574406349
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406349
ARGININEMIA	0.009317484000000001	0.11532373574406349
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406349
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406349
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.11532373574406349
MUCOLIPIDOSIS TYPE IV	0.009287280000000002	0.1149498968284921
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00925926	0.11460308957070141
AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT	0.00925926	0.11460308957070141
NEUROFIBROMA	0.00925926	0.11460308957070141
OTITIS MEDIA, SUSCEPTIBILITY TO; OMS	0.00925926	0.11460308957070141
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00925926	0.11460308957070141
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00925926	0.11460308957070141
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00925926	0.11460308957070141
CILIARY DYSKINESIA, PRIMARY, 21; CILD21	0.00925926	0.11460308957070141
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00925926	0.11460308957070141
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575343
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009161724	0.11339587355728693
COFFIN-SIRIS SYNDROME 2; CSS2	0.009161724	0.11339587355728693
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.009161724	0.11339587355728693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.009161724	0.11339587355728693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009161724	0.11339587355728693
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009161724	0.11339587355728693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.009161724	0.11339587355728693
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009160123999999999	0.11337607014499339
MACHADO-JOSEPH DISEASE TYPE 3	0.00915114	0.11326487398496515
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00915114	0.11326487398496515
LARYNGOTRACHEAL ANGIOMA	0.00915114	0.11326487398496515
MACHADO-JOSEPH DISEASE TYPE 1	0.00915114	0.11326487398496515
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00915114	0.11326487398496515
MACHADO-JOSEPH DISEASE TYPE 2	0.00915114	0.11326487398496515
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009059484	0.11213043551172945
CHAR SYNDROME	0.009037264	0.11185541562350287
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009037264	0.11185541562350287
CHROMOSOME 15Q25 DELETION SYNDROME	0.009022084	0.11166753074936786
JOUBERT SYNDROME 2	0.009020134	0.11164339534063512
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.009020134	0.11164339534063512
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009020134	0.11164339534063512
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.11164339534063512
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009020134	0.11164339534063512
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009020134	0.11164339534063512
OROFACIODIGITAL SYNDROME VI	0.009020134	0.11164339534063512
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.11164339534063512
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.11164339534063512
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	0.11164339534063512
RING CHROMOSOME 12 SYNDROME	0.009020134	0.11164339534063512
OROFACIODIGITAL SYNDROME TYPE 6	0.009020134	0.11164339534063512
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009020134	0.11164339534063512
ADAMS-OLIVER SYNDROME 1; AOS1	0.009020134	0.11164339534063512
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.009020134	0.11164339534063512
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009020134	0.11164339534063512
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009020134	0.11164339534063512
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00896098	0.11091123843387743
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00894701	0.11073832989028942
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00894701	0.11073832989028942
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00894701	0.11073832989028942
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00894701	0.11073832989028942
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.008884504000000001	0.10996468483477675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008884504000000001	0.10996468483477675
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.008884504000000001	0.10996468483477675
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.008833134	0.10932887152882713
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.008833134	0.10932887152882713
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.008802830000000001	0.10895379489998741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008781394000000001	0.10868847868378466
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008781394000000001	0.10868847868378466
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.008781394000000001	0.10868847868378466
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008781394000000001	0.10868847868378466
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.10857134150006834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.10857134150006834
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.10857134150006834
BREATH-HOLDING SPELLS	0.00877193	0.10857134150006834
PINEOBLASTOMA	0.00877193	0.10857134150006834
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.10857134150006834
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.10857134150006834
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.10857134150006834
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.10857134150006834
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.10857134150006834
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.10857134150006834
MILROY DISEASE	0.00877193	0.10857134150006834
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.10857134150006834
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.10857134150006834
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.10857134150006834
HUNTINGTON DISEASE	0.00877193	0.10857134150006834
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.10857134150006834
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006834
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.10857134150006834
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.10857134150006834
CAFFEY DISEASE	0.00877193	0.10857134150006834
CRYPTOCOCCOSIS	0.00877193	0.10857134150006834
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.10857134150006834
KEIPERT SYNDROME	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.10857134150006834
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.10857134150006834
SNEDDON SYNDROME	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.10857134150006834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.10857134150006834
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.10857134150006834
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.10857134150006834
CORTICOBASAL SYNDROME	0.00877193	0.10857134150006834
HISTIDINEMIA	0.00877193	0.10857134150006834
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.10857134150006834
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.10857134150006834
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.10857134150006834
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.10857134150006834
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.10857134150006834
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.10857134150006834
LESCH-NYHAN SYNDROME	0.00877193	0.10857134150006834
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.008652739999999999	0.10709611105552612
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.008652739999999999	0.10709611105552612
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.008652739999999999	0.10709611105552612
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.10709611105552612
DISTAL MONOSOMY 10P	0.008652739999999999	0.10709611105552612
NEONATAL ADRENOLEUKODYSTROPHY	0.008652739999999999	0.10709611105552612
LAMB-SHAFFER SYNDROME	0.008621753999999999	0.10671259322219626
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00861617	0.10664347931329181
9Q21.13 MICRODELETION SYNDROME	0.00861617	0.10664347931329181
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00861617	0.10664347931329181
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00861617	0.10664347931329181
20Q13.33 MICRODELETION SYNDROME	0.00861617	0.10664347931329181
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008502294	0.10523402095182954
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.008502294	0.10523402095182954
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.008502294	0.10523402095182954
JOUBERT SYNDROME 14	0.008502294	0.10523402095182954
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.008502294	0.10523402095182954
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008502294	0.10523402095182954
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.008502294	0.10523402095182954
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008502294	0.10523402095182954
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008502294	0.10523402095182954
DOORS SYNDROME	0.008502294	0.10523402095182954
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00849171	0.10510302137950772
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00847458	0.10489100109663999
PACHYGYRIA, FRONTOTEMPORAL	0.00847458	0.10489100109663999
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.10489100109663999
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.10489100109663999
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.10489100109663999
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.10489100109663999
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.10489100109663999
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.10489100109663999
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.10489100109663999
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.10489100109663999
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.10489100109663999
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.10489100109663999
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.10489100109663999
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.10489100109663999
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.10489100109663999
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.10489100109663999
TUFTED ANGIOMA	0.00847458	0.10489100109663999
SCLEROSTEOSIS 1; SOST1	0.00847458	0.10489100109663999
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.10489100109663999
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00847458	0.10489100109663999
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.10489100109663999
WIEDEMANN-STEINER SYNDROME; WDSTS	0.008434984	0.10440091615090549
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008434984	0.10440091615090549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008434984	0.10440091615090549
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.008338950000000001	0.10321229059078162
MOEBIUS SYNDROME	0.00828758	0.10257647728483198
CHIME SYNDROME	0.00828758	0.10257647728483198
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.10193608443978953
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.008235840000000001	0.10193608443978953
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00814257	0.10078166927440273
STEVENS-JOHNSON SYNDROME	0.00814257	0.10078166927440273
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.008103054	0.10029257449928292
SOTOS SYNDROME 2	0.0080762	0.09996019897820115
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00795674	0.09848162670783439
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00795674	0.09848162670783439
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00795674	0.09848162670783439
PROTEUS SYNDROME	0.00795674	0.09848162670783439
KABUKI SYNDROME	0.00795674	0.09848162670783439
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.09843489065482161
300270 ADRENOMYODYSTROPHY	0.007952964	0.09843489065482161
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007952964	0.09843489065482161
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.09843489065482161
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.09843489065482161
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.09843489065482161
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.007914794	0.09796245550029375
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.007914794	0.09796245550029375
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.007914794	0.09796245550029375
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.007914794	0.09796245550029375
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007914794	0.09796245550029375
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00788943	0.09764852190691035
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0078545	0.09721618866227692
GM1 GANGLIOSIDOSIS	0.0078545	0.09721618866227692
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007791934	0.09644180097880324
PRIMARY CONGENITAL HYPOTHYROIDISM	0.007791934	0.09644180097880324
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007791934	0.09644180097880324
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.09644180097880324
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.007791934	0.09644180097880324
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007791934	0.09644180097880324
PERIPHERAL HYPOTHYROIDISM	0.007791934	0.09644180097880324
BAND HETEROTOPIA; BH	0.007791934	0.09644180097880324
SEVERE CANAVAN DISEASE	0.007791934	0.09644180097880324
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412751
17Q12 MICRODELETION SYNDROME	0.007587804	0.09391525688412751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412751
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412751
COWDEN SYNDROME	0.007587804	0.09391525688412751
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.09168249641082649
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082649
FRYNS SYNDROME	0.00740741	0.09168249641082649
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.09168249641082649
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.09168249641082649
BOWEN-CONRADI SYNDROME	0.00740741	0.09168249641082649
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082649
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.09168249641082649
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.09168249641082649
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082649
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082649
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082649
CROME SYNDROME	0.00740741	0.09168249641082649
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082649
YUNIS-VARON SYNDROME	0.00740741	0.09168249641082649
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082649
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.09168249641082649
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082649
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082649
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.09168249641082649
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.09168249641082649
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.09168249641082649
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.09168249641082649
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082649
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082649
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082649
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082649
DPM1-CDG	0.00740741	0.09168249641082649
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.09168249641082649
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00736924	0.09121006125629862
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00736924	0.09121006125629862
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00736924	0.09121006125629862
MICROTIA	0.00736924	0.09121006125629862
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00736924	0.09121006125629862
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.007292764	0.09026350765719796
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007256964	0.0898204063071299
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.0898204063071299
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.0898204063071299
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.007256964	0.0898204063071299
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.007256964	0.0898204063071299
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.0898204063071299
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.0898204063071299
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.007256964	0.0898204063071299
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.007256964	0.0898204063071299
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.0898204063071299
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007256964	0.0898204063071299
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007256964	0.0898204063071299
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.007256964	0.0898204063071299
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.0898204063071299
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	0.0898204063071299
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007256964	0.0898204063071299
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.0898204063071299
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.0898204063071299
CITRULLINEMIA, CLASSIC	0.007256964	0.0898204063071299
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	0.0898204063071299
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	0.0898204063071299
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	0.0898204063071299
AICARDI-GOUTIERES SYNDROME 5	0.007256964	0.0898204063071299
AICARDI-GOUTIÈRES SYNDROME	0.007256964	0.0898204063071299
NARP SYNDROME	0.007256964	0.0898204063071299
JOUBERT SYNDROME 10	0.007256964	0.0898204063071299
SHWACHMAN-DIAMOND SYNDROME	0.007256964	0.0898204063071299
ARGININOSUCCINIC ACIDURIA	0.007256964	0.0898204063071299
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.0898204063071299
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007256964	0.0898204063071299
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.007256964	0.0898204063071299
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.0898204063071299
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.007255364	0.08980060289483635
8P23.1 MICRODELETION SYNDROME	0.007255364	0.08980060289483635
19P13.13 MICRODELETION SYNDROME	0.007255364	0.08980060289483635
INCONTINENTIA PIGMENTI	0.007255364	0.08980060289483635
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.0896894067348081
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00724638	0.0896894067348081
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.0896894067348081
HEREDITARY HYPEREKPLEXIA	0.00724638	0.0896894067348081
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00724638	0.0896894067348081
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00724638	0.0896894067348081
NEURALGIC AMYOTROPHY	0.00724638	0.0896894067348081
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.0896894067348081
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.0896894067348081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.007189654	0.08898730150620586
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.007189654	0.08898730150620586
11P15.4 MICRODUPLICATION SYNDROME	0.007189654	0.08898730150620586
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.007189654	0.08898730150620586
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.007189654	0.08898730150620586
3C SYNDROME	0.007154724	0.08855496826157241
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.007054104	0.08730958117096216
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.007054104	0.08730958117096216
RING CHROMOSOME 13 SYNDROME	0.00704225	0.08716286264013236
NANCE-HORAN SYNDROME	0.00704225	0.08716286264013236
GOLDENHAR SYNDROME	0.00704225	0.08716286264013236
HYPERLEXIA	0.00704225	0.08716286264013236
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013236
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00683087	0.0845465843335015
MEIER-GORLIN SYNDROME 6; MGORS6	0.00674721	0.08351111341320282
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00671141	0.08306801206313476
IMMUNODEFICIENCY 32A	0.00671141	0.08306801206313476
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.08306801206313476
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00671141	0.08306801206313476
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00671141	0.08306801206313476
IDIOPATHIC APLASTIC ANEMIA	0.00671141	0.08306801206313476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313476
UROCANIC ACIDURIA	0.00671141	0.08306801206313476
LETTERER-SIWE DISEASE	0.00671141	0.08306801206313476
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.08306801206313476
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.00671141	0.08306801206313476
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.08306801206313476
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.08306801206313476
TUFTSIN DEFICIENCY	0.00671141	0.08306801206313476
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313476
IMMUNODEFICIENCY 55; IMD55	0.00671141	0.08306801206313476
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	0.08306801206313476
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	0.08306801206313476
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00671141	0.08306801206313476
LAZY LEUKOCYTE SYNDROME	0.00671141	0.08306801206313476
BULLOUS PEMPHIGOID	0.00671141	0.08306801206313476
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	0.08306801206313476
IMMUNODEFICIENCY 52; IMD52	0.00671141	0.08306801206313476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313476
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00671141	0.08306801206313476
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313476
224250 DYSMYELINATION WITH JAUNDICE	0.00671141	0.08306801206313476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.08306801206313476
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313476
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00671141	0.08306801206313476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00671141	0.08306801206313476
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313476
HYPOPHOSPHATASIA	0.00671141	0.08306801206313476
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.08306801206313476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313476
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	0.08306801206313476
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00671141	0.08306801206313476
CYSTIC DISEASE OF LUNG	0.00671141	0.08306801206313476
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313476
WALDENSTRÖM MACROGLOBULINEMIA	0.00671141	0.08306801206313476
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00671141	0.08306801206313476
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.08306801206313476
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.08306801206313476
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00671141	0.08306801206313476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00671141	0.08306801206313476
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.08306801206313476
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313476
IMMUNODEFICIENCY 37; IMD37	0.00671141	0.08306801206313476
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313476
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	0.08306801206313476
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00671141	0.08306801206313476
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.00671141	0.08306801206313476
BEHCET SYNDROME	0.00671141	0.08306801206313476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00671141	0.08306801206313476
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00671141	0.08306801206313476
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.08306801206313476
CONGENITAL ATRANSFERRINEMIA	0.00671141	0.08306801206313476
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.08306801206313476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313476
BETA-THALASSEMIA	0.00671141	0.08306801206313476
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.08306801206313476
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313476
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313476
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313476
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00671141	0.08306801206313476
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	0.08306801206313476
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	0.08306801206313476
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00670981	0.08304820865084121
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.006707694	0.083022018638083
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.006707694	0.083022018638083
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.006707694	0.083022018638083
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00660917	0.08180257401757728
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00660917	0.08180257401757728
ACROOSTEOLYSIS DOMINANT TYPE	0.00660917	0.08180257401757728
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00660917	0.08180257401757728
LEPRECHAUNISM	0.00660917	0.08180257401757728
ACERULOPLASMINEMIA	0.0063492	0.07858489083385685
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0063492	0.07858489083385685
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.006336334000000001	0.07842564664475139
MALAN OVERGROWTH SYNDROME	0.00617144	0.07638473172804408
RENPENNING SYNDROME 1; RENS1	0.00617144	0.07638473172804408
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.006047434	0.0748498930124983
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.0743869882501367
MARDEN-WALKER SYNDROME	0.006010034	0.0743869882501367
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.0743869882501367
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.0743869882501367
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00598467	0.0740730546567533
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00598467	0.0740730546567533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005946814000000001	0.07360450592188805
RETINAL CONE DYSTROPHY 3B	0.005790780000000001	0.07167325240075625
HIDROTIC ECTODERMAL DYSPLASIA	0.005790780000000001	0.07167325240075625
OCULOCUTANEOUS ALBINISM	0.005790780000000001	0.07167325240075625
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.005790780000000001	0.07167325240075625
OCULOCUTANEOUS ALBINISM TYPE 2	0.005790780000000001	0.07167325240075625
X-LINKED RECESSIVE OCULAR ALBINISM	0.005790780000000001	0.07167325240075625
LEBER CONGENITAL AMAUROSIS 16	0.005790780000000001	0.07167325240075625
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005790780000000001	0.07167325240075625
GAPO SYNDROME; GAPOS	0.005790780000000001	0.07167325240075625
XERODERMA PIGMENTOSUM	0.005790780000000001	0.07167325240075625
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.005790780000000001	0.07167325240075625
OCULOCUTANEOUS ALBINISM TYPE 1B	0.005790780000000001	0.07167325240075625
HERMANSKY-PUDLAK SYNDROME	0.005790780000000001	0.07167325240075625
OCULOCUTANEOUS ALBINISM TYPE 4	0.005790780000000001	0.07167325240075625
OCULAR ALBINISM	0.005790780000000001	0.07167325240075625
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00568977	0.07042303822839943
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00568977	0.07042303822839943
GAUCHER DISEASE	0.00568977	0.07042303822839943
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00550188	0.06809749876850316
CHITAYAT SYNDROME	0.00550188	0.06809749876850316
19Q13.11 MICRODELETION SYNDROME	0.00550188	0.06809749876850316
ALAZAMI SYNDROME; ALAZS	0.005471664	0.06772351132733959
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733959
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733959
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614157
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.06763459400614157
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.06763459400614157
LEGIUS SYNDROME	0.00546448	0.06763459400614157
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614157
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614157
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614157
CHROMOSOME 9P DELETION SYNDROME	0.005462364	0.06760840399338336
SIALIDOSIS TYPE 2	0.005462364	0.06760840399338336
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.005462364	0.06760840399338336
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005462364	0.06760840399338336
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.005462364	0.06760840399338336
COFFIN-SIRIS SYNDROME	0.005388004	0.06668804040704089
WOLF-HIRSCHHORN SYNDROME	0.005388004	0.06668804040704089
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.005388004	0.06668804040704089
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005287384000000001	0.06544265331643064
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.005287384000000001	0.06544265331643064
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005287384000000001	0.06544265331643064
HADZISELIMOVIC SYNDROME	0.005287384000000001	0.06544265331643064
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.005287384000000001	0.06544265331643064
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005287384000000001	0.06544265331643064
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005287384000000001	0.06544265331643064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005287384000000001	0.06544265331643064
OPTIC ATROPHY 11; OPA11	0.005287384000000001	0.06544265331643064
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005287384000000001	0.06544265331643064
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005287384000000001	0.06544265331643064
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005287384000000001	0.06544265331643064
PONTINE TEGMENTAL CAP DYSPLASIA	0.005287384000000001	0.06544265331643064
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005287384000000001	0.06544265331643064
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.005287384000000001	0.06544265331643064
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.005287384000000001	0.06544265331643064
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.0654118342560488
JAWAD SYNDROME	0.005284894	0.0654118342560488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.0654118342560488
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005284894	0.0654118342560488
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.005284894	0.0654118342560488
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.0654118342560488
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.005284894	0.0654118342560488
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.0654118342560488
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.0654118342560488
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005175
L1 SYNDROME	0.004989994	0.06176181782769493
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769493
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.06097111708334445
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.06097111708334445
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.06097111708334445
GENIOSPASM 1; GSM1	0.00492611	0.06097111708334445
PANIC DISORDER 1	0.00492611	0.06097111708334445
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.06097111708334445
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.06097111708334445
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00491681	0.06085600974938822
GAUCHER DISEASE TYPE 2	0.00484245	0.05993564616304575
GAUCHER DISEASE TYPE 3	0.00484245	0.05993564616304575
JACOBSEN SYNDROME	0.00484245	0.05993564616304575
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00484245	0.05993564616304575
STICKLER SYNDROME	0.00484245	0.05993564616304575
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004802934	0.05944655138792594
BOHRING-OPITZ SYNDROME	0.004802934	0.05944655138792594
ARTERIAL TORTUOSITY SYNDROME	0.004802934	0.05944655138792594
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.004802934	0.05944655138792594
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.004802934	0.05944655138792594
2Q31.1 MICRODELETION SYNDROME	0.004802934	0.05944655138792594
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004802934	0.05944655138792594
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004802934	0.05944655138792594
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004802934	0.05944655138792594
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004802934	0.05944655138792594
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.004802934	0.05944655138792594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004741830000000001	0.0586902590724355
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004741830000000001	0.0586902590724355
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.05865944001205366
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.05865944001205366
MENTAL RETARDATION, X-LINKED 102	0.00473934	0.05865944001205366
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.05865944001205366
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.05865944001205366
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.05865944001205366
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.05865944001205366
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.05865944001205366
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.05865944001205366
YELLOW FEVER	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.05625963775605661
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.05625963775605661
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.05625963775605661
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.05625963775605661
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.05625963775605661
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.05625963775605661
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.05625963775605661
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.05625963775605661
SCRUB TYPHUS	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.05625963775605661
RETINAL CONE DYSTROPHY 4	0.00454545	0.05625963775605661
CONE DYSTROPHY 3	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.05625963775605661
BLAU SYNDROME	0.00454545	0.05625963775605661
OLIGOCONE TRICHROMACY	0.00454545	0.05625963775605661
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.05625963775605661
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 10	0.00454545	0.05625963775605661
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.05625963775605661
ALBINISM, OCULAR, TYPE I	0.00454545	0.05625963775605661
CORNEAL FLECK DYSTROPHY	0.00454545	0.05625963775605661
SJÖGREN-LARSSON SYNDROME	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.05625963775605661
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.05625963775605661
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.05625963775605661
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.05625963775605661
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.05625963775605661
ERMINE PHENOTYPE	0.00454545	0.05625963775605661
CONE DYSTROPHY 4	0.00454545	0.05625963775605661
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.05625963775605661
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 17	0.00454545	0.05625963775605661
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.05625963775605661
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.05625963775605661
LEUKONYCHIA TOTALIS	0.00454545	0.05625963775605661
MACULAR CORNEAL DYSTROPHY	0.00454545	0.05625963775605661
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.05625963775605661
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.05625963775605661
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00454545	0.05625963775605661
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.05625963775605661
AMOEBIC KERATITIS	0.00454545	0.05625963775605661
COGAN SYNDROME	0.00454545	0.05625963775605661
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.05625963775605661
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.05625963775605661
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.05625963775605661
ALACRIMA	0.00454545	0.05625963775605661
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.05625963775605661
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 79	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.05625963775605661
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.05625963775605661
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.05625963775605661
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00454545	0.05625963775605661
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.05625963775605661
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.05625963775605661
ALPORT SYNDROME	0.00454545	0.05625963775605661
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.05625963775605661
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 16	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.05625963775605661
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.05625963775605661
ACHROMATOPSIA 7; ACHM7	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.05625963775605661
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.05625963775605661
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.05625963775605661
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.05625963775605661
IRVAN SYNDROME	0.00454545	0.05625963775605661
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.05625963775605661
JALILI SYNDROME	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.05625963775605661
NEOVASCULAR GLAUCOMA	0.00454545	0.05625963775605661
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.05625963775605661
TYROSINEMIA TYPE 2	0.00454545	0.05625963775605661
BRADYOPSIA	0.00454545	0.05625963775605661
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.05625963775605661
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.05625963775605661
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.05625963775605661
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.05625963775605661
IDIOPATHIC PANUVEITIS	0.00454545	0.05625963775605661
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.05625963775605661
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.05625963775605661
CONE ROD DYSTROPHY	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.05625963775605661
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.05625963775605661
BLUE CONE MONOCHROMATISM	0.00454545	0.05625963775605661
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.05625963775605661
EEC SYNDROME	0.00454545	0.05625963775605661
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.05625963775605661
FLOTCH SYNDROME	0.00454545	0.05625963775605661
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.05625963775605661
ALACRIMA, CONGENITAL	0.00454545	0.05625963775605661
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.05500942358369979
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369979
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.05500942358369979
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00444444	0.05500942358369979
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.05500942358369979
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.05500942358369979
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.05500942358369979
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.05500942358369979
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.05500942358369979
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.05500942358369979
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.05500942358369979
GLUCAGONOMA	0.00444444	0.05500942358369979
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.05500942358369979
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.05500942358369979
CENTRAL NEUROCYTOMA	0.00444444	0.05500942358369979
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.05500942358369979
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.05500942358369979
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.05500942358369979
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369979
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00425738	0.0526941571439308
TRISOMY 20P	0.00425738	0.0526941571439308
FOCAL DERMAL HYPOPLASIA; FDH	0.00425738	0.0526941571439308
SHPRINTZEN-GOLDBERG SYNDROME	0.00425738	0.0526941571439308
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00425738	0.0526941571439308
ACROCALLOSAL SYNDROME; ACLS	0.00425738	0.0526941571439308
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00425738	0.0526941571439308
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00425738	0.0526941571439308
SCARF SYNDROME	0.00425738	0.0526941571439308
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00425738	0.0526941571439308
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00425738	0.0526941571439308
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00425738	0.0526941571439308
PALLISTER-KILLIAN SYNDROME	0.00425738	0.0526941571439308
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00425738	0.0526941571439308
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00425738	0.0526941571439308
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00425738	0.0526941571439308
SCARF SYNDROME	0.00425738	0.0526941571439308
FEMORAL-FACIAL SYNDROME	0.00425738	0.0526941571439308
MARDEN-WALKER SYNDROME	0.00425738	0.0526941571439308
FOCAL DERMAL HYPOPLASIA	0.00425738	0.0526941571439308
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004142674	0.05127442576234125
ICF SYNDROME	0.004142674	0.05127442576234125
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.004142674	0.05127442576234125
TAY-SACHS DISEASE	0.004142674	0.05127442576234125
HEREDITARY OROTIC ACIDURIA	0.004142674	0.05127442576234125
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004142674	0.05127442576234125
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.004142674	0.05127442576234125
TETRASOMY 5P	0.004142674	0.05127442576234125
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004142674	0.05127442576234125
FREE SIALIC ACID STORAGE DISEASE	0.004142674	0.05127442576234125
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004142674	0.05127442576234125
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.004142674	0.05127442576234125
DYSKERATOSIS CONGENITA	0.004142674	0.05127442576234125
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004142674	0.05127442576234125
EARLY MYOCLONIC ENCEPHALOPATHY	0.004142674	0.05127442576234125
FARBER DISEASE	0.004142674	0.05127442576234125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004042054000000001	0.050029038671731
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004042054000000001	0.050029038671731
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004042054000000001	0.050029038671731
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004042054000000001	0.050029038671731
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.050029038671731
CHROMOSOME 1P35 DELETION SYNDROME	0.004042054000000001	0.050029038671731
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004042054000000001	0.050029038671731
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004042054000000001	0.050029038671731
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004042054000000001	0.050029038671731
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004042054000000001	0.050029038671731
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004042054000000001	0.050029038671731
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004042054000000001	0.050029038671731
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004042054000000001	0.050029038671731
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004042054000000001	0.050029038671731
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004042054000000001	0.050029038671731
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004042054000000001	0.050029038671731
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.050029038671731
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004042054000000001	0.050029038671731
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.050029038671731
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004042054000000001	0.050029038671731
MENTAL RETARDATION, X-LINKED 103	0.004042054000000001	0.050029038671731
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004042054000000001	0.050029038671731
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.004042054000000001	0.050029038671731
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004042054000000001	0.050029038671731
PEHO-LIKE SYNDROME; PEHOL	0.004042054000000001	0.050029038671731
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004042054000000001	0.050029038671731
FOIX-CHAVANY-MARIE SYNDROME	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004042054000000001	0.050029038671731
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004042054000000001	0.050029038671731
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.050029038671731
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004042054000000001	0.050029038671731
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004042054000000001	0.050029038671731
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004042054000000001	0.050029038671731
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004042054000000001	0.050029038671731
LISSENCEPHALY 8; LIS8	0.004042054000000001	0.050029038671731
IMMUNODEFICIENCY 49; IMD49	0.004042054000000001	0.050029038671731
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.004042054000000001	0.050029038671731
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004042054000000001	0.050029038671731
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004042054000000001	0.050029038671731
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.050029038671731
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004042054000000001	0.050029038671731
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004042054000000001	0.050029038671731
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004042054000000001	0.050029038671731
JOUBERT SYNDROME 24	0.004042054000000001	0.050029038671731
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004042054000000001	0.050029038671731
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004042054000000001	0.050029038671731
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004042054000000001	0.050029038671731
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004042054000000001	0.050029038671731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004042054000000001	0.050029038671731
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.050029038671731
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0036956439999999997	0.04574147613885183
6Q TERMINAL DELETION SYNDROME	0.0036956439999999997	0.04574147613885183
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0036956439999999997	0.04574147613885183
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0036956439999999997	0.04574147613885183
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0036956439999999997	0.04574147613885183
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.0036956439999999997	0.04574147613885183
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0036956439999999997	0.04574147613885183
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0036956439999999997	0.04574147613885183
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0036956439999999997	0.04574147613885183
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0036956439999999997	0.04574147613885183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0036956439999999997	0.04574147613885183
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0036956439999999997	0.04574147613885183
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036956439999999997	0.04574147613885183
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0036956439999999997	0.04574147613885183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0036956439999999997	0.04574147613885183
1Q44 MICRODELETION SYNDROME	0.0036956439999999997	0.04574147613885183
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0036956439999999997	0.04574147613885183
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0036956439999999997	0.04574147613885183
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0036956439999999997	0.04574147613885183
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0036956439999999997	0.04574147613885183
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0036956439999999997	0.04574147613885183
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.04452203151834611
VAN DEN BOSCH SYNDROME	0.00359712	0.04452203151834611
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00359712	0.04452203151834611
PRIMARY ERYTHROMELALGIA	0.00359712	0.04452203151834611
DERMATOMYOSITIS	0.00359712	0.04452203151834611
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00359712	0.04452203151834611
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00359712	0.04452203151834611
ODONTOCHONDRODYSPLASIA; ODCD	0.00359712	0.04452203151834611
PAROXYSMAL COLD HEMOGLOBINURIA	0.00359712	0.04452203151834611
IMMUNODEFICIENCY 32B; IMD32B	0.00359712	0.04452203151834611
RETICULAR DYSGENESIS	0.00359712	0.04452203151834611
SANDHOFF DISEASE	0.00359712	0.04452203151834611
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00359712	0.04452203151834611
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00359712	0.04452203151834611
ATAXIA-PANCYTOPENIA SYNDROME	0.00359712	0.04452203151834611
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00359712	0.04452203151834611
BETA-MANNOSIDOSIS	0.00359712	0.04452203151834611
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00359712	0.04452203151834611
IMMUNODEFICIENCY 43	0.00359712	0.04452203151834611
LARYNX ATRESIA	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.00359712	0.04452203151834611
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00359712	0.04452203151834611
OPSISMODYSPLASIA	0.00359712	0.04452203151834611
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00359712	0.04452203151834611
CYSTIC FIBROSIS	0.00359712	0.04452203151834611
ALOPECIA ANTIBODY DEFICIENCY	0.00359712	0.04452203151834611
PULMONARY ARTERIAL HYPERTENSION	0.00359712	0.04452203151834611
LIPOID PROTEINOSIS	0.00359712	0.04452203151834611
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00359712	0.04452203151834611
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00359712	0.04452203151834611
GRANULOMATOSIS WITH POLYANGIITIS	0.00359712	0.04452203151834611
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00359712	0.04452203151834611
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00359712	0.04452203151834611
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00359712	0.04452203151834611
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00359712	0.04452203151834611
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00359712	0.04452203151834611
THORACIC DYSOSTOSIS, ISOLATED	0.00359712	0.04452203151834611
LAMELLAR ICHTHYOSIS	0.00359712	0.04452203151834611
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.00359712	0.04452203151834611
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00359712	0.04452203151834611
LYMPHANGIOLEIOMYOMATOSIS	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.00359712	0.04452203151834611
ZLOTOGORA-OGUR SYNDROME	0.00359712	0.04452203151834611
IMMUNODEFICIENCY 22; IMD22	0.00359712	0.04452203151834611
HENNEKAM SYNDROME	0.00359712	0.04452203151834611
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00359712	0.04452203151834611
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.00359712	0.04452203151834611
GAMMA-HEAVY CHAIN DISEASE	0.00359712	0.04452203151834611
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00359712	0.04452203151834611
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.00359712	0.04452203151834611
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00359712	0.04452203151834611
MARTSOLF SYNDROME	0.00359712	0.04452203151834611
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00359712	0.04452203151834611
DIASTROPHIC DWARFISM	0.00359712	0.04452203151834611
RETINITIS PIGMENTOSA 6	0.00359712	0.04452203151834611
IMMUNODEFICIENCY 57; IMD57	0.00359712	0.04452203151834611
CHRONIC GRANULOMATOUS DISEASE	0.00359712	0.04452203151834611
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00359712	0.04452203151834611
MALT LYMPHOMA	0.00359712	0.04452203151834611
NIEMANN-PICK DISEASE, TYPE B	0.00359712	0.04452203151834611
BLOOM SYNDROME	0.00359712	0.04452203151834611
PARTIAL ATRIOVENTRICULAR CANAL	0.00359712	0.04452203151834611
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00359712	0.04452203151834611
GLYCOGEN STORAGE DISEASE II	0.00359712	0.04452203151834611
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00359712	0.04452203151834611
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00359712	0.04452203151834611
MELNICK-NEEDLES SYNDROME	0.00359712	0.04452203151834611
JUNG SYNDROME	0.00359712	0.04452203151834611
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.00359712	0.04452203151834611
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00359712	0.04452203151834611
SANJAD-SAKATI SYNDROME	0.00359712	0.04452203151834611
CYCLIC NEUTROPENIA	0.00359712	0.04452203151834611
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00359712	0.04452203151834611
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00359712	0.04452203151834611
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.00359712	0.04452203151834611
YELLOW NAIL SYNDROME	0.00359712	0.04452203151834611
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00359712	0.04452203151834611
SPINAL MUSCULAR ATROPHY, TYPE II	0.00359712	0.04452203151834611
WISKOTT-ALDRICH SYNDROME	0.00359712	0.04452203151834611
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.00359712	0.04452203151834611
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00359712	0.04452203151834611
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00359712	0.04452203151834611
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00359712	0.04452203151834611
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00359712	0.04452203151834611
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00359712	0.04452203151834611
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00359712	0.04452203151834611
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00359712	0.04452203151834611
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.00359712	0.04452203151834611
OPSISMODYSPLASIA; OPSMD	0.00359712	0.04452203151834611
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.04452203151834611
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00359712	0.04452203151834611
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00359712	0.04452203151834611
SPASTIC PARAPLEGIA TYPE 2	0.00359712	0.04452203151834611
HYPEREKPLEXIA 4; HKPX4	0.003557604	0.0440329367432263
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003557604	0.0440329367432263
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.003557604	0.0440329367432263
KAGAMI-OGATA SYNDROME	0.003557604	0.0440329367432263
17P13.3 MICRODUPLICATION SYNDROME	0.003557604	0.0440329367432263
PETERS PLUS SYNDROME	0.003557604	0.0440329367432263
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.003557604	0.0440329367432263
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003557604	0.0440329367432263
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003557604	0.0440329367432263
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003557604	0.0440329367432263
CATEL-MANZKE SYNDROME; CATMANS	0.003557604	0.0440329367432263
RUVALCABA SYNDROME	0.003557604	0.0440329367432263
DIAPHANOSPONDYLODYSOSTOSIS	0.003557604	0.0440329367432263
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003557604	0.0440329367432263
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.003557604	0.0440329367432263
KAGAMI-OGATA SYNDROME	0.003557604	0.0440329367432263
PERLMAN SYNDROME	0.003557604	0.0440329367432263
LATERAL MENINGOCELE SYNDROME	0.003557604	0.0440329367432263
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003557604	0.0440329367432263
AYMÉ-GRIPP SYNDROME	0.003557604	0.0440329367432263
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003557604	0.0440329367432263
PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.0440329367432263
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003557604	0.0440329367432263
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003557604	0.0440329367432263
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.0440329367432263
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003557604	0.0440329367432263
OROFACIODIGITAL SYNDROME XVI; OFD16	0.003557604	0.0440329367432263
WEAVER SYNDROME	0.003557604	0.0440329367432263
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.04327664442773586
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.04327664442773586
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.04327664442773586
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.04327664442773586
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.04327664442773586
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0034965000000000005	0.04327664442773586
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.04327664442773586
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.04327664442773586
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.04327664442773586
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.04327664442773586
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.04327664442773586
14Q12 MICRODELETION SYNDROME	0.0034965000000000005	0.04327664442773586
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.04327664442773586
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.04327664442773586
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0034965000000000005	0.04327664442773586
OLIVER SYNDROME	0.0034965000000000005	0.04327664442773586
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.04327664442773586
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0034965000000000005	0.04327664442773586
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0034965000000000005	0.04327664442773586
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0034965000000000005	0.04327664442773586
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.04327664442773586
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.04327664442773586
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.04327664442773586
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.04327664442773586
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.04327664442773586
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00315009	0.0389890818948567
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00315009	0.0389890818948567
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00315009	0.0389890818948567
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00315009	0.0389890818948567
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00315009	0.0389890818948567
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00301205	0.03728054249923117
HUNTER-MACDONALD SYNDROME	0.00301205	0.03728054249923117
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00301205	0.03728054249923117
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	0.03728054249923117
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00301205	0.03728054249923117
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00301205	0.03728054249923117
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00301205	0.03728054249923117
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, TYPE I	0.00301205	0.03728054249923117
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00301205	0.03728054249923117
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	0.03728054249923117
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00301205	0.03728054249923117
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00301205	0.03728054249923117
HYPEREKPLEXIA 1; HKPX1	0.00301205	0.03728054249923117
VACTERL WITH HYDROCEPHALUS	0.00301205	0.03728054249923117
OSTEOGENESIS IMPERFECTA	0.00301205	0.03728054249923117
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	0.03728054249923117
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00301205	0.03728054249923117
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	0.03728054249923117
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	0.03728054249923117
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.00301205	0.03728054249923117
WIDOW'S PEAK SYNDROME	0.00301205	0.03728054249923117
OMPHALOCELE, AUTOSOMAL	0.00301205	0.03728054249923117
LAMBERT SYNDROME	0.00301205	0.03728054249923117
HERNIA, DOUBLE INGUINAL	0.00301205	0.03728054249923117
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	0.03728054249923117
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	0.03728054249923117
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00301205	0.03728054249923117
MUCOLIPIDOSIS TYPE III	0.00301205	0.03728054249923117
268650 RUDIGER SYNDROME	0.00301205	0.03728054249923117
EXSTROPHY OF BLADDER	0.00301205	0.03728054249923117
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923117
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	0.03728054249923117
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	0.03728054249923117
ACROCALLOSAL SYNDROME	0.00301205	0.03728054249923117
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	0.03728054249923117
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00301205	0.03728054249923117
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	0.03728054249923117
ADAMS-OLIVER SYNDROME 5; AOS5	0.00301205	0.03728054249923117
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00301205	0.03728054249923117
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00301205	0.03728054249923117
X-LINKED EHLERS-DANLOS SYNDROME	0.00301205	0.03728054249923117
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00301205	0.03728054249923117
SHORT SYNDROME	0.00301205	0.03728054249923117
BRITTLE CORNEA SYNDROME 2; BCS2	0.00301205	0.03728054249923117
LATERAL MENINGOCELE SYNDROME	0.00301205	0.03728054249923117
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	0.03728054249923117
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00301205	0.03728054249923117
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	0.03728054249923117
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00301205	0.03728054249923117
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	0.03728054249923117
RHINY	0.00301205	0.03728054249923117
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	0.03728054249923117
DISTAL MONOSOMY 3P	0.00301205	0.03728054249923117
FRANK-TER HAAR SYNDROME	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00301205	0.03728054249923117
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	0.03728054249923117
BRUCK SYNDROME 2	0.00301205	0.03728054249923117
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	0.03728054249923117
RUVALCABA SYNDROME	0.00301205	0.03728054249923117
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	0.03728054249923117
ARTERIAL TORTUOSITY SYNDROME	0.00301205	0.03728054249923117
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00301205	0.03728054249923117
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00301205	0.03728054249923117
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00301205	0.03728054249923117
POLYDACTYLY-MYOPIA SYNDROME	0.00301205	0.03728054249923117
NEURAMINIDASE DEFICIENCY	0.00301205	0.03728054249923117
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00301205	0.03728054249923117
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00301205	0.03728054249923117
AUTOSOMAL DOMINANT CUTIS LAXA	0.00301205	0.03728054249923117
DIPHALLIA	0.00301205	0.03728054249923117
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00301205	0.03728054249923117
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	0.03728054249923117
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00301205	0.03728054249923117
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00301205	0.03728054249923117
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	0.03728054249923117
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	0.03728054249923117
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00301205	0.03728054249923117
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	0.03728054249923117
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	0.03728054249923117
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00301205	0.03728054249923117
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	0.03728054249923117
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00301205	0.03728054249923117
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923117
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923117
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	0.03728054249923117
FACIOCARDIORENAL SYNDROME	0.00301205	0.03728054249923117
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	0.03728054249923117
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	0.03728054249923117
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	0.03728054249923117
ISOLATED HEMIHYPERPLASIA	0.00301205	0.03728054249923117
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00301205	0.03728054249923117
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00301205	0.03728054249923117
LAMBERT SYNDROME	0.00301205	0.03728054249923117
COFFIN-LOWRY SYNDROME; CLS	0.00301205	0.03728054249923117
ACHONDROGENESIS	0.00301205	0.03728054249923117
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	0.03728054249923117
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	0.03728054249923117
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	0.03728054249923117
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00301205	0.03728054249923117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002450314	0.03032786149415219
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002450314	0.03032786149415219
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.03032786149415219
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002450314	0.03032786149415219
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002450314	0.03032786149415219
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.03032786149415219
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002450314	0.03032786149415219
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.03032786149415219
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002450314	0.03032786149415219
EPILEPSY, PYRIDOXINE-DEPENDENT	0.002450314	0.03032786149415219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002450314	0.03032786149415219
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.03032786149415219
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.03032786149415219
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.03032786149415219
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002450314	0.03032786149415219
AL KAISSI SYNDROME; ALKAS	0.002450314	0.03032786149415219
EPIDERMAL NEVUS SYNDROME	0.002450314	0.03032786149415219
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.03032786149415219
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.03032786149415219
SHASHI-PENA SYNDROME; SHAPNS	0.002450314	0.03032786149415219
NOONAN SYNDROME 6; NS6	0.002450314	0.03032786149415219
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.03032786149415219
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002450314	0.03032786149415219
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.002450314	0.03032786149415219
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.03032786149415219
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.002450314	0.03032786149415219
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.03032786149415219
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.03032786149415219
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.03032786149415219
LIG4 SYNDROME	0.002450314	0.03032786149415219
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002450314	0.03032786149415219
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.002450314	0.03032786149415219
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002450314	0.03032786149415219
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.002450314	0.03032786149415219
SAY-BARBER-MILLER SYNDROME	0.002450314	0.03032786149415219
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.03032786149415219
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.03032786149415219
FORSYTHE-WAKELING SYNDROME; FWS	0.002450314	0.03032786149415219
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002450314	0.03032786149415219
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.002450314	0.03032786149415219
8P23.1 DUPLICATION SYNDROME	0.002450314	0.03032786149415219
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002450314	0.03032786149415219
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002450314	0.03032786149415219
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.03032786149415219
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002450314	0.03032786149415219
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002450314	0.03032786149415219
GALACTOSE EPIMERASE DEFICIENCY	0.002450314	0.03032786149415219
17Q11.2 MICRODUPLICATION SYNDROME	0.002450314	0.03032786149415219
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.03032786149415219
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002450314	0.03032786149415219
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.03032786149415219
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002450314	0.03032786149415219
OKAMOTO SYNDROME	0.002450314	0.03032786149415219
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002450314	0.03032786149415219
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.03032786149415219
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002450314	0.03032786149415219
12Q14 MICRODELETION SYNDROME	0.002450314	0.03032786149415219
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.03032786149415219
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002450314	0.03032786149415219
GENITOPATELLAR SYNDROME	0.002450314	0.03032786149415219
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.03032786149415219
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.002450314	0.03032786149415219
PELIZAEUS-MERZBACHER DISEASE	0.002450314	0.03032786149415219
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.002450314	0.03032786149415219
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.002450314	0.03032786149415219
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.03032786149415219
7P22.1 MICRODUPLICATION SYNDROME	0.002450314	0.03032786149415219
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.023575467250157054
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.023575467250157054
CRANIOSYNOSTOSIS 7	0.00190476	0.023575467250157054
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.023575467250157054
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.023575467250157054
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00190476	0.023575467250157054
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.023575467250157054
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.023575467250157054
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.023575467250157054
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.023575467250157054
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.023575467250157054
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00190476	0.023575467250157054
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.023575467250157054
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.023575467250157054
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.023575467250157054
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.023575467250157054
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.023575467250157054
FG SYNDROME 2; FGS2	0.00190476	0.023575467250157054
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.023575467250157054
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.023575467250157054
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00190476	0.023575467250157054
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.023575467250157054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.023575467250157054
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.023575467250157054
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.023575467250157054
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.023575467250157054
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.023575467250157054
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.023575467250157054
EPISODIC ATAXIA TYPE 1	0.00190476	0.023575467250157054
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.023575467250157054
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.023575467250157054
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.023575467250157054
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.023575467250157054
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.023575467250157054
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.023575467250157054
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	0.023575467250157054
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.023575467250157054
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.023575467250157054
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.023575467250157054
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.023575467250157054
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00190476	0.023575467250157054
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.023575467250157054
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.023575467250157054
20P13 MICRODELETION SYNDROME	0.00190476	0.023575467250157054
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00190476	0.023575467250157054
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00190476	0.023575467250157054
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	0.023575467250157054
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.023575467250157054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.023575467250157054
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.023575467250157054
NAGER SYNDROME	0.00190476	0.023575467250157054
MASA SYNDROME	0.00190476	0.023575467250157054
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.023575467250157054
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	0.023575467250157054
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.023575467250157054
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.023575467250157054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.023575467250157054
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.023575467250157054
DYSTONIA 16; DYT16	0.00190476	0.023575467250157054
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	0.023575467250157054
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.023575467250157054
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.023575467250157054
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.023575467250157054
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.023575467250157054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.023575467250157054
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.023575467250157054
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.023575467250157054
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.023575467250157054
PARTINGTON SYNDROME	0.00190476	0.023575467250157054
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.023575467250157054
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.023575467250157054
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.023575467250157054
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.023575467250157054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.023575467250157054
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.023575467250157054
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.023575467250157054
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.023575467250157054
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	0.023575467250157054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.023575467250157054
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.023575467250157054
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.023575467250157054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.023575467250157054
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.023575467250157054
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.023575467250157054
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001790884	0.02216600888869478
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001790884	0.02216600888869478
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001790884	0.02216600888869478
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001790884	0.02216600888869478
CRANIOSYNOSTOSIS 6; CRS6	0.001790884	0.02216600888869478
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001790884	0.02216600888869478
MONOSOMY 9P	0.001790884	0.02216600888869478
TRISOMY 17P	0.001790884	0.02216600888869478
RAHMAN SYNDROME	0.001790884	0.02216600888869478
SENIOR-LOKEN SYNDROME 9	0.001790884	0.02216600888869478
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.02216600888869478
XQ21 MICRODELETION SYNDROME	0.001790884	0.02216600888869478
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.02216600888869478
CARDIOFACIOCUTANEOUS SYNDROME	0.001790884	0.02216600888869478
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001790884	0.02216600888869478
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001790884	0.02216600888869478
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.02216600888869478
TOLUENE EMBRYOPATHY	0.001790884	0.02216600888869478
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.02216600888869478
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.02216600888869478
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.02216600888869478
JOUBERT SYNDROME 21	0.001790884	0.02216600888869478
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.02216600888869478
POTOCKI-SHAFFER SYNDROME	0.001790884	0.02216600888869478
PHACE SYNDROME	0.001790884	0.02216600888869478
SCHINDLER DISEASE, TYPE I	0.001790884	0.02216600888869478
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.02216600888869478
SCHIZENCEPHALY	0.001790884	0.02216600888869478
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.02216600888869478
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.02216600888869478
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.02216600888869478
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.02216600888869478
TREACHER-COLLINS SYNDROME	0.001790884	0.02216600888869478
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.02216600888869478
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.02216600888869478
KBG SYNDROME	0.001790884	0.02216600888869478
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001790884	0.02216600888869478
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001790884	0.02216600888869478
DUANE RETRACTION SYNDROME	0.001790884	0.02216600888869478
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001790884	0.02216600888869478
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001790884	0.02216600888869478
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.02216600888869478
ZTTK SYNDROME; ZTTKS	0.001790884	0.02216600888869478
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.02216600888869478
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001790884	0.02216600888869478
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.02216600888869478
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.02216600888869478
MEIER-GORLIN SYNDROME 7	0.001790884	0.02216600888869478
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.02216600888869478
MATERNAL PHENYLKETONURIA	0.001790884	0.02216600888869478
JOUBERT SYNDROME WITH RENAL DEFECT	0.001790884	0.02216600888869478
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.02216600888869478
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.02216600888869478
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001790884	0.02216600888869478
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.02216600888869478
CODAS SYNDROME	0.001790884	0.02216600888869478
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001790884	0.02216600888869478
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.02216600888869478
MARINESCO-SJÖGREN SYNDROME	0.001790884	0.02216600888869478
GERMAN SYNDROME	0.001790884	0.02216600888869478
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.02216600888869478
OPTIC PATHWAY GLIOMA	0.001790884	0.02216600888869478
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.02216600888869478
ROTHMUND-THOMSON SYNDROME	0.001790884	0.02216600888869478
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.02216600888869478
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.02216600888869478
JOUBERT SYNDROME	0.001790884	0.02216600888869478
MONOSOMY 18Q	0.001790884	0.02216600888869478
3MC SYNDROME 2	0.001790884	0.02216600888869478
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.02216600888869478
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.02216600888869478
COHEN SYNDROME	0.001790884	0.02216600888869478
X SMALL RINGS	0.001790884	0.02216600888869478
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.02216600888869478
OCULOECTODERMAL SYNDROME; OES	0.001790884	0.02216600888869478
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.02216600888869478
FRONTOOCULAR SYNDROME	0.001790884	0.02216600888869478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001790884	0.02216600888869478
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.02216600888869478
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.02216600888869478
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.02216600888869478
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001790884	0.02216600888869478
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001790884	0.02216600888869478
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.02216600888869478
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.02216600888869478
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	0.02216600888869478
SSR4-CDG	0.001790884	0.02216600888869478
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001790884	0.02216600888869478
ISOLATED PLAGIOCEPHALY	0.001790884	0.02216600888869478
BOHRING-OPITZ SYNDROME	0.001790884	0.02216600888869478
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001790884	0.02216600888869478
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.02216600888869478
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001790884	0.02216600888869478
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.02216600888869478
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.02216600888869478
MONOSOMY 9Q22.3	0.001790884	0.02216600888869478
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001790884	0.02216600888869478
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.02216600888869478
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.015413614644699638
MULTIMINICORE MYOPATHY	0.00124533	0.015413614644699638
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00124533	0.015413614644699638
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.015413614644699638
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00124533	0.015413614644699638
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.015413614644699638
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.015413614644699638
BASAL CELL NEVUS SYNDROME	0.00124533	0.015413614644699638
ROBINOW-SORAUF SYNDROME	0.00124533	0.015413614644699638
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.015413614644699638
NOONAN SYNDROME	0.00124533	0.015413614644699638
IVIC SYNDROME	0.00124533	0.015413614644699638
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.015413614644699638
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.015413614644699638
MOSAIC TRISOMY 8	0.00124533	0.015413614644699638
NANOPHTHALMOS	0.00124533	0.015413614644699638
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.015413614644699638
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.015413614644699638
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.015413614644699638
WOOLLY HAIR	0.00124533	0.015413614644699638
MORNING GLORY DISC ANOMALY	0.00124533	0.015413614644699638
MEIER-GORLIN SYNDROME 1; MGORS1	0.00124533	0.015413614644699638
BRANCHIOOCULOFACIAL SYNDROME	0.00124533	0.015413614644699638
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.015413614644699638
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.015413614644699638
COOPER-JABS SYNDROME	0.00124533	0.015413614644699638
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.015413614644699638
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.015413614644699638
HYPERTELORISM, TEEBI TYPE	0.00124533	0.015413614644699638
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.015413614644699638
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.015413614644699638
15Q OVERGROWTH SYNDROME	0.00124533	0.015413614644699638
JACKSON-WEISS SYNDROME	0.00124533	0.015413614644699638
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.015413614644699638
KNOBLOCH SYNDROME	0.00124533	0.015413614644699638
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.015413614644699638
MCDONOUGH SYNDROME	0.00124533	0.015413614644699638
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.015413614644699638
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.015413614644699638
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.015413614644699638
NON-DISTAL MONOSOMY 10Q	0.00124533	0.015413614644699638
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.015413614644699638
IVIC SYNDROME	0.00124533	0.015413614644699638
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.015413614644699638
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.015413614644699638
ODONTOCHONDRODYSPLASIA	0.00124533	0.015413614644699638
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.015413614644699638
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699638
LAURENCE-MOON SYNDROME	0.00124533	0.015413614644699638
COCKAYNE SYNDROME A; CSA	0.00124533	0.015413614644699638
TRISOMY 4P	0.00124533	0.015413614644699638
LEIGH SYNDROME	0.00124533	0.015413614644699638
CARTILAGE-HAIR HYPOPLASIA	0.00124533	0.015413614644699638
MARSHALL SYNDROME	0.00124533	0.015413614644699638
ABDUCENS PALSY	0.00124533	0.015413614644699638
APERT SYNDROME	0.00124533	0.015413614644699638
MCDONOUGH SYNDROME	0.00124533	0.015413614644699638
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.015413614644699638
HALLERMANN-STREIFF SYNDROME	0.00124533	0.015413614644699638
X-LINKED RETINAL DYSPLASIA	0.00124533	0.015413614644699638
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.015413614644699638
TETRASOMY 12P	0.00124533	0.015413614644699638
15Q26 OVERGROWTH SYNDROME	0.00124533	0.015413614644699638
CROUZON DISEASE	0.00124533	0.015413614644699638
GASTROCUTANEOUS SYNDROME	0.00124533	0.015413614644699638
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.015413614644699638
LAMBOTTE SYNDROME	0.00124533	0.015413614644699638
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.015413614644699638
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00124533	0.015413614644699638
EEM SYNDROME	0.00124533	0.015413614644699638
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699638
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.015413614644699638
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.015413614644699638
COCKAYNE SYNDROME	0.00124533	0.015413614644699638
WAARDENBURG SYNDROME TYPE 1	0.00124533	0.015413614644699638
FETAL IODINE SYNDROME	0.00124533	0.015413614644699638
JOHANSON-BLIZZARD SYNDROME; JBS	0.00124533	0.015413614644699638
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00124533	0.015413614644699638
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699638
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.015413614644699638
MUSCLE-EYE-BRAIN DISEASE	0.00124533	0.015413614644699638
PROXIMAL SYMPHALANGISM	0.00124533	0.015413614644699638
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.015413614644699638
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.015413614644699638
RETINOBLASTOMA	0.00124533	0.015413614644699638
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.015413614644699638
SUMMITT SYNDROME	0.00124533	0.015413614644699638
NOONAN SYNDROME 7; NS7	0.00124533	0.015413614644699638
DYSEQUILIBRIUM SYNDROME	0.00124533	0.015413614644699638
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.015413614644699638
GLUTATHIONURIA	0.00124533	0.015413614644699638
TOWNES-BROCKS SYNDROME	0.00124533	0.015413614644699638
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.015413614644699638
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.015413614644699638
RENPENNING SYNDROME	0.00124533	0.015413614644699638
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.015413614644699638
CONGENITAL HYDROCEPHALUS	0.00124533	0.015413614644699638
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.015413614644699638
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00124533	0.015413614644699638
DIAMOND-BLACKFAN ANEMIA 1	0.00124533	0.015413614644699638
SECKEL SYNDROME 5; SCKL5	0.00124533	0.015413614644699638
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00124533	0.015413614644699638
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699638
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	0.015413614644699638
ALAGILLE SYNDROME	0.00124533	0.015413614644699638
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.015413614644699638
DESMOSTEROLOSIS	0.00124533	0.015413614644699638
MOWAT-WILSON SYNDROME	0.00124533	0.015413614644699638
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.015413614644699638
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.015413614644699638
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.015413614644699638
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	0.015413614644699638
PETERS ANOMALY	0.00124533	0.015413614644699638
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699638
RENAL COLOBOMA SYNDROME	0.00124533	0.015413614644699638
HEMIFACIAL MICROSOMIA	0.00124533	0.015413614644699638
MASA SYNDROME	0.00124533	0.015413614644699638
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.015413614644699638
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.015413614644699638
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.015413614644699638
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.015413614644699638
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.015413614644699638
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.015413614644699638
PELVISCAPULAR DYSPLASIA	0.00124533	0.015413614644699638
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.015413614644699638
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00124533	0.015413614644699638
ADAMS-OLIVER SYNDROME	0.00124533	0.015413614644699638
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	0.015413614644699638
FANCONI ANEMIA	0.00124533	0.015413614644699638
ANTLEY-BIXLER SYNDROME	0.00124533	0.015413614644699638
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.015413614644699638
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.015413614644699638
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.015413614644699638
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	0.015413614644699638
SECKEL SYNDROME 1; SCKL1	0.00124533	0.015413614644699638
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	0.015413614644699638
COATS DISEASE	0.00124533	0.015413614644699638
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.015413614644699638
BRANCHIOSKELETOGENITAL SYNDROME	0.00124533	0.015413614644699638
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.015413614644699638
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.015413614644699638
BENCZE SYNDROME	0.00124533	0.015413614644699638
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.015413614644699638
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.015413614644699638
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.015413614644699638
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.015413614644699638
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.015413614644699638
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00124533	0.015413614644699638
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.015413614644699638
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00124533	0.015413614644699638
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00124533	0.015413614644699638
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00124533	0.015413614644699638
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.015413614644699638
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.015413614644699638
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.015413614644699638
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.015413614644699638
PETERS ANOMALY	0.00124533	0.015413614644699638
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.015413614644699638
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.015413614644699638
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.015413614644699638
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.015413614644699638
STIFF SKIN SYNDROME	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.015413614644699638
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.015413614644699638
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	0.015413614644699638
CHANARIN-DORFMAN SYNDROME	0.00124533	0.015413614644699638
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.015413614644699638
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.015413614644699638
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.015413614644699638
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.015413614644699638
CROSSED POLYSYNDACTYLY	0.00124533	0.015413614644699638
SENGERS SYNDROME	0.00124533	0.015413614644699638
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.015413614644699638
COSTELLO SYNDROME	0.00124533	0.015413614644699638
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.015413614644699638
CONGENITAL RUBELLA SYNDROME	0.00124533	0.015413614644699638
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.015413614644699638
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.015413614644699638
LERI PLEONOSTEOSIS	0.00124533	0.015413614644699638
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	0.015413614644699638
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.015413614644699638
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.015413614644699638
INCONTINENTIA PIGMENTI; IP	0.00124533	0.015413614644699638
FRONTORHINY	0.00124533	0.015413614644699638
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699638
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699638
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.015413614644699638
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.015413614644699638
OTOMANDIBULAR SYNDROME	0.00124533	0.015413614644699638
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00124533	0.015413614644699638
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.015413614644699638
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.015413614644699638
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.015413614644699638
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00124533	0.015413614644699638
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.015413614644699638
LINEAR VERRUCOUS NEVUS SYNDROME	0.00124533	0.015413614644699638
ELLIS VAN CREVELD SYNDROME	0.00124533	0.015413614644699638
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.015413614644699638
OPTIC ATROPHY 1; OPA1	0.00124533	0.015413614644699638
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00124533	0.015413614644699638
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.015413614644699638
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.015413614644699638
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995139
ALG6-CDG	0.000545554	0.006752394243995139
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.006752394243995139
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995139
RIGID SPINE SYNDROME	0.000545554	0.006752394243995139
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.006752394243995139
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995139
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995139
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995139
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995139
LIG4 SYNDROME	0.000545554	0.006752394243995139
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995139
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995139
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995139
ALG3-CDG	0.000545554	0.006752394243995139
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995139
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995139
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995139
MONOSOMY 13Q34	0.000545554	0.006752394243995139
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995139
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.006752394243995139
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.006752394243995139
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995139
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995139
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995139
RECOMBINANT 8 SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995139
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995139
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995139
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.006752394243995139
WOLMAN DISEASE	0.000545554	0.006752394243995139
THYROID HYPOPLASIA	0.000545554	0.006752394243995139
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995139
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995139
COACH SYNDROME	0.000545554	0.006752394243995139
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995139
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995139
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995139
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.006752394243995139
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995139
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995139
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995139
KBG SYNDROME	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995139
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995139
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.006752394243995139
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995139
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995139
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995139
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995139
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.006752394243995139
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995139
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.006752394243995139
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995139
MOSAIC TRISOMY 9	0.000545554	0.006752394243995139
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995139
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995139
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.006752394243995139
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995139
DPAGT1-CDG	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.006752394243995139
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.006752394243995139
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.006752394243995139
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995139
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995139
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995139
BRESEK SYNDROME	0.000545554	0.006752394243995139
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.006752394243995139
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995139
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.006752394243995139
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995139
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995139
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.006752394243995139
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995139
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.006752394243995139
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995139
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995139
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995139
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995139
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995139
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.006752394243995139
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995139
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995139
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995139
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.006752394243995139
CANAVAN DISEASE	0.000545554	0.006752394243995139
STEEL SYNDROME; STLS	0.000545554	0.006752394243995139
CINCA SYNDROME	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995139
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995139
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995139
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995139
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995139
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995139
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.006752394243995139
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995139
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995139
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.006752394243995139
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.006752394243995139
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995139
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995139
NOONAN SYNDROME 11; NS11	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995139
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.006752394243995139
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995139
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995139
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995139
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.006752394243995139
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995139
EAST SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995139
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995139
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995139
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995139
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995139
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995139
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.006752394243995139
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.006752394243995139
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995139
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995139
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995139
LISSENCEPHALY 4	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.006752394243995139
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.006752394243995139
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY	0.000545554	0.006752394243995139
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995139
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995139
HYDRANENCEPHALY	0.000545554	0.006752394243995139
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995139
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995139
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995139
JOUBERT SYNDROME 15	0.000545554	0.006752394243995139
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995139
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995139
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995139
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995139
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995139
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.006752394243995139
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995139
TRISOMY 12P	0.000545554	0.006752394243995139
MOSAIC TRISOMY 14	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.006752394243995139
DISTAL TRISOMY 18Q	0.000545554	0.006752394243995139
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.006752394243995139
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995139
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.006752394243995139
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.006752394243995139
TRISOMY 8Q	0.000545554	0.006752394243995139
TEMTAMY SYNDROME	0.000545554	0.006752394243995139
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995139
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.006752394243995139
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995139
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.006752394243995139
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995139
JOUBERT SYNDROME 27	0.000545554	0.006752394243995139
JOUBERT SYNDROME 28	0.000545554	0.006752394243995139
ALAZAMI-YUAN SYNDROME	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995139
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.006752394243995139
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995139
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995139
CHOPS SYNDROME; CHOPS	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.006752394243995139
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995139
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995139
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995139
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995139
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995139
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.006752394243995139
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995139
JOUBERT SYNDROME 25	0.000545554	0.006752394243995139
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995139
AU-KLINE SYNDROME; AUKS	0.000545554	0.006752394243995139
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995139
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995139
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995139
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995139
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995139
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995139
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995139
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995139
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995139
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995139
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.006752394243995139
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.006752394243995139
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.006752394243995139
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995139
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995139
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995139
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995139
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.006752394243995139
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.006752394243995139
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995139
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995139
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995139
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995139
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995139
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.006752394243995139
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.006752394243995139
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.006752394243995139
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995139
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995139
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995139
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995139
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995139
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.006752394243995139
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995139
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995139
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995139
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995139
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995139
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995139
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.006752394243995139
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.006752394243995139
TARP SYNDROME; TARPS	0.000545554	0.006752394243995139
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995139
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995139
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.006752394243995139
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995139
STT3A-CDG	0.000545554	0.006752394243995139
STT3B-CDG	0.000545554	0.006752394243995139
GRISCELLI SYNDROME	0.000545554	0.006752394243995139
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995139
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995139
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.006752394243995139
MEND SYNDROME; MEND	0.000545554	0.006752394243995139
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995139
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995139
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995139
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995139
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995139
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995139
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995139
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995139
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995139
SRD5A3-CDG	0.000545554	0.006752394243995139
CURRY-JONES SYNDROME	0.000545554	0.006752394243995139
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.006752394243995139
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995139
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995139
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995139
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.006752394243995139
DISTAL TRISOMY 17Q	0.000545554	0.006752394243995139
TRISOMY 18	0.000545554	0.006752394243995139
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995139
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995139
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.006752394243995139
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995139
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995139
CODAS SYNDROME	0.000545554	0.006752394243995139
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995139
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995139
FUCOSIDOSIS	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995139
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.006752394243995139
GALACTOSEMIA	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.006752394243995139
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.006752394243995139
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995139
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995139
PEHO SYNDROME; PEHO	0.000545554	0.006752394243995139
RAINE SYNDROME	0.000545554	0.006752394243995139
OROTIC ACIDURIA	0.000545554	0.006752394243995139
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995139
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995139
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.006752394243995139
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.006752394243995139
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.006752394243995139
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995139
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995139
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995139
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995139
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995139
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.006752394243995139
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995139
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995139
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995139
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995139
MACDERMOT-WINTER SYNDROME	0.000545554	0.006752394243995139
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995139
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995139
KETOADIPICACIDURIA	0.000545554	0.006752394243995139
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.006752394243995139
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995139
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995139
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.006752394243995139
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.006752394243995139
COG2-CDG	0.000545554	0.006752394243995139
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995139
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.006752394243995139
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.006752394243995139
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995139
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995139
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.006752394243995139
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995139
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.006752394243995139
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995139
LATHOSTEROLOSIS	0.000545554	0.006752394243995139
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.006752394243995139
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.006752394243995139
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995139
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995139
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995139
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.006752394243995139
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995139
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995139
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.006752394243995139
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995139
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.006752394243995139
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.006752394243995139
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995139
JOUBERT SYNDROME 7	0.000545554	0.006752394243995139
NOONAN SYNDROME 5; NS5	0.000545554	0.006752394243995139
N SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995139
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995139
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995139
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995139
JOUBERT SYNDROME 6	0.000545554	0.006752394243995139
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995139
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.006752394243995139
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.006752394243995139
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995139
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.006752394243995139
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.006752394243995139
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995139
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.006752394243995139
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995139
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.006752394243995139
JOUBERT SYNDROME 8	0.000545554	0.006752394243995139
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995139
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995139
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995139
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.006752394243995139
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.006752394243995139
TRISOMY 9P	0.000545554	0.006752394243995139
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995139
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995139
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.006752394243995139
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995139
RFT1-CDG	0.000545554	0.006752394243995139
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.006752394243995139
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.006752394243995139
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.006752394243995139
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995139
MICRO SYNDROME	0.000545554	0.006752394243995139
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.006752394243995139
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995139
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995139
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
8P11.2 DELETION SYNDROME	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995139
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995139
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995139
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995139
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995139
CDAGS SYNDROME	0.000545554	0.006752394243995139
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.006752394243995139
MEVALONIC ACIDURIA	0.000545554	0.006752394243995139
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995139
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995139
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995139
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995139
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.006752394243995139
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995139
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995139
PHACE ASSOCIATION	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.006752394243995139
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995139
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.006752394243995139
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995139
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995139
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995139
ROBERTS SYNDROME	0.000545554	0.006752394243995139
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.006752394243995139
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995139
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.006752394243995139
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995139
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995139
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.006752394243995139
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995139
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.006752394243995139
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995139
TARP SYNDROME	0.000545554	0.006752394243995139
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.006752394243995139
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995139
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.006752394243995139
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.006752394243995139
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995139
FRIAS SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.006752394243995139
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995139
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.006752394243995139
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995139
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995139
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995139
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995139
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995139
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.006752394243995139
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995139
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.006752394243995139
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995139
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995139
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995139
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995139
